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ABSTRACT
Nigeria has some of the highest rates of cervical cancer morbidity and mortality in 
sub-Saharan Africa. Both the human papillomavirus vaccine (HPV) and cervical screening 
are effective prevention strategies against both HPV infection and cervical cancer. Lack of 
awareness, limited knowledge, limited decision-making agency, lack of spousal support 
and stigma are barriers to uptake of these preventive measures. Given patriarchal structures 
and norms through which men control family resources and dominate decisions, male 
involvement in initiatives aimed at improving sexual and reproductive health is necessary. 
Community-based health education is an effective intervention to improve knowledge and 
reduce stigma. The aim of this research was to evaluate the impact of an 
educational intervention on awareness, knowledge, intention to take HPV vaccination and 
cervical screening, and reduce stigma among men and women offered at 12 urban 
community locations in Nigeria. This is a pre-test and post-test study that employed two 
community-based health education interventions; a face-to-face presentation delivered in 
group settings and printed pamphlet delivered to individuals. A total of 266 participants 
within 18 and 65 years participated.  
At baseline, the majority (80%) of all participants had low levels of knowledge of 
HPV and HPV vaccine and 21% had limited knowledge of cervical cancer and cervical 
screening.  The proportion of participants with poor knowledge of HPV and cervical cancer 
reduced significantly at post-intervention in both groups. Our results showed that less than 
12% of all participants had ever received HPV vaccine and screening.  There was 
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significant increase in the participants’ intention to take and to encourage a family member 
to receive HPV vaccination and cervical cancer screening. Of note, knowledge of HPV as 
a sexually transmitted infection was associated with high levels of stigma, which increased 
after exposure to the intervention.  
The research supported the effectiveness of the community-based educational 
intervention in promoting the increasing awareness, knowledge and intention to take HPV 
vaccine and cervical screening among urban-dwelling Nigerian adults. Study findings are 
important for informing future gender-comprehensive and context-specific programs 
activities that seek to engage men in reducing HPV infection and cervical cancer in Sub-
Saharan Africa. Further research is warranted to assess the factors contributing to ongoing 
stigma and to develop effective interventions to reduce stigma among Nigerian adults. 
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CHAPTER 1 
INTRODUCTION
Background 
Human Papillomavirus (HPV) refers to small, double-stranded DNA viruses with 
more than 150 identified types. Each virus is classified according to their oncogenic 
potential into low-risk and high-risk HPV types (Centers for Disease Control and 
Prevention, [CDC] 2017). HPV is the most common sexually transmitted infection, 
commonly spread through intimate skin-to-skin contact by having vaginal, anal, or oral 
sex. HPV transmission from hands to genitals or genitals to hands have also reported for 
both sexes and heterosexual couples (Liu, 2016). HPV has been found to be resistant to 
heat and desiccation, therefore non-sexual transmission of the virus is possible (Ault, 
2006). HPV is so common that most sexually active men and women will be infected with 
at least one type of HPV at some point in their lives. It is difficult to detect when an 
individual first became infected with HPV as symptoms can develop years after infection 
(CDC, 2017).  
The vast majority of HPV infection is asymptomatic and will clear without medical 
intervention; but those who contract persistent high-risk HPV types may develop cancer. 
HPV is estimated to cause about 5% of human cancers (de Martel et al., 2012; Bosch et al, 
2013), including anogenital cancers (cervical, vaginal, vulvar, penile, and anal) and 
oropharyngeal cancer (CDC, 2017). The prevalence of HPV among general population is 
unknown in Nigeria but studies had reported 42.9% of women in a state in the northern 
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region (Aminu et al., 2014) and 26.3% of the general population in Southern Nigeria had 
HPV-IgG antibodies (Aminu et al., 2014; Bruni et al., 2014; Okolo et al., 2010). 
Furthermore, the age-specific prevalence revealed that 52% of Nigerian women ≤ 30 years 
had an HPV infection compared to 23% of women who were older than 45 years (Akarolo-
Anthony et al., 2014).  
HPV infection is responsible for more than 90% of cervical cancers (CDC, 2017), 
and Nigeria has one of the most extensive epidemics of cervical cancer in sub-Saharan 
Africa (Ferlay et al., 2014; Oguntayo et al., 2011). Cervical cancer is the second most 
common female cancer in many parts of Nigeria (Oguntayo et al., 2011), with a high 
incidence and mortality rates. On average, one Nigerian woman dies of cervical cancer 
every hour (Federal Ministry of Health [FMoH], 2014). The age-standardized incidence 
rate of cervical cancer is 34.5 per 100,000 (Ferlay et al., 2014). There is an upsurge in 
invasive cases, as retrospective studies in three tertiary hospitals in three different regions 
(Jos, Zaria, and Nnewi) of the country, found that more than 70% of the patients presented 
with advanced stage cervical cancer (Ikechebelu, Onyiaorah, Ugboaja, Anyiam, & Eleje, 
2010; Musa et al., 2016; Oguntayo et al., 2011).  
Even with the reported high burden of cervical cancer in Nigeria, accurate 
morbidity and mortality rates are unknown, due to gross underreporting, misdiagnosis, 
suboptimal record keeping and improper data from poorly funded cancer registries. It is 
predicted that there will be 19,440 new cervical cancer cases and 10,991 cervical cancer 
deaths by 2025 in Nigeria (Ferlay et al., 2014). The risk of HPV infection and cervical 
cancer can be significantly reduced by HPV vaccination, Pap smear, Visual Inspection with 
Acetic Acid (VIA) and HPV test.  
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Prevention  
HPV Vaccine. HPV vaccines have fostered the hope of eradication of HPV 
infection and cervical cancer. The two types of HPV vaccines, Gardasil™and Cervarix™ 
provide protection against HPV infection. Gardasil is a quadrivalent vaccine that protects 
against HPV types 6, 11, 16, and 18, while Gardasil-9 is a nine-valent HPV vaccine that 
protects against HPV types 6, 11, 16, 18, 31, 45, 52, and 58 (CDC, 2016). Cervarix is a 
bivalent vaccine that gives protection against HPV types 16 and 18. The World Health 
Organization (WHO) recommends HPV vaccines for boys and girls aged 9 through 26 
(WHO, 2014), while Center for Disease Control and Prevention recommends HPV 
vaccination for preteen girls and boys at age 11 or 12 years and teens and young adults who 
did not start or finish the vaccine series until they are 27 years old for women and 22 years 
old for men. Two doses of HPV vaccine at least six months apart was recommended for 
11- to 12-year-olds, and a three doses series is recommended for teens and young adults 
who start the vaccine later than ages 15 (CDC, 2016). 
The 2015 HPV vaccination guidelines by the American College of Obstetricians 
and Gynecologist Committee do not recommend testing for HPV DNA prior to vaccination 
in any population group; recommend vaccination among individuals who test positive to 
HPV DNA and do not recommend routine pregnancy testing before HPV vaccination. 
However, the guidelines warn that HPV vaccine should not be taken in pregnancy. HPV 
vaccination is recommended for women regardless of sexual activity status (Munoz, et al. 
2010; Paavonen, et al. 2010); for individuals who did not receive the vaccine at an early 
age, and for men and women with compromised immune systems (including people living 
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with HIV/AIDS) through age 26, if they did not get fully vaccinated when they were 
younger (CDC, 2014).  
Cervical Cancer Screening. HPV vaccination is projected to reduce substantial 
prevalence of specific HPV 16/18 infections, cervical abnormalities and invasive cervical 
cancer, if population coverage is high above 70% (WHO, 2009). Once in a lifetime 
screening, performed by women in their 30s or 40s could reduce the risk of cervical cancer 
by 25-30% (WHO, 2014). The implementation of Pap smear, Visual Inspection with Acetic 
Acid (VIA) and HPV screening is essential for detecting the HPV virus and early cell 
changes on the cervix. Pap smear and VIA facilitates early detection and successful 
treatment of precancerous cervical lesions. Pap smear is recommended for all women 
between the ages of 21 and 65 years old (CDC, 2016). Women who are 30 years old or 
older are encouraged to have an HPV test along with the Pap smear (CDC, 2016). The HPV 
test is a “qualitative multiplex assay that simultaneously provides specific genotyping 
information for HPV types 16 and 18, and a pooled result of 12 high risk strains of HPV 
DNA’’ (Roche Molecular Inc., 2014, p.10). HPV tests eliminates the need for an initial 
pelvic exam by providing women an opportunity to collect samples of their own vaginal 
cells for testing (Arbyn et al, 2014). With normal pap test results, a woman is expected to 
wait for three years before repeating another Pap test (CDC, 2017; Ronco et al., 2014). 
With normal HPV test and Pap test results, a woman can wait as long as 5 years before 
getting another screening test (Ronco et al., 2014), as her chances of getting cervical cancer 
in the next few years is very low (CDC, 2017).  
The World Health Organization (WHO), together with CDC and other health 
organizations included visual inspection with acetic acid (VIA) and treatment with 
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cryotherapy in the cervical cancer screening guidelines as screening methods for cervical 
cancer in low-resource settings (WHO, 2013; CDC, 2015). VIA involves staining the 
cervix with a 5% acetic acid (vinegar) solution, and an abnormal cervical tissue turns white 
after 30 to 60 seconds. VIA has helped increase the detection of precancerous cells by 
increasing screening coverage in some developing countries (WHO, 2012; Quentin et al., 
2011; Nessa et al., 2010; Zhang et al., 2010; Mwanahamuntu, et al., 2011; Mwanahamuntu, 
et al., 2013). In Nigeria, the uptake of cervical cancer screening is extremely low, as fewer 
than 10% of Nigerian women have ever had a cervical cancer screening (Idowu, 
Olowookere, Fagbemi, & Ogunlaja, 2016; Wright, Aiyedehin, Akinyinka, & Ilozumba, 
2014). Poor uptake of cervical cancer screening was documented even among health 
providers in Lagos Nigeria, where 60% of the nurses reported never having been screened 
for cervical cancer (Awodele et al., 2011). 
Barriers  
The low uptake of HPV vaccine and cervical cancer screening in Nigeria is 
exacerbated by multiple personal, social, political and institutional factors. Reported 
barriers include: lack of awareness of the vaccine; poor knowledge of disease and screening 
techniques; erroneous perceptions, cultural beliefs and practices; fear of pain from the 
procedure; fear of the outcome of the test; lack of decision making ability and spousal 
support; stigma and modesty, the cost of screening, barrier to access, associated costs, 
deficiencies within the health care system and health facilities (Ezenwa, Balogun, & 
Okafor, 2013; Lim & Ojo, 2017; Modibbo, et al., 2016; Ndikom, Ofi & Omokhodion, 
2014). Even among urban and educated Nigerian women, the level of awareness and 
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knowledge of cervical cancer were found to be low (Hyacinth, Adekeye, Ibeh & Osoba, 
2012).  
With prevention and early detection, HPV infection and cervical cancer are largely 
avoidable diseases.  The incidence of HPV infection and cervical cancer are very high in 
Nigeria due to poor uptake of cervical cancer screening measures and HPV vaccine. 
Cervical cancer has a profound societal impact as it mainly affects women between the 
ages of 30 to 50, who are often raising or supporting families (Goumbri, Domagni, Sanou, 
Konsegre, & Soudre, 2009). Although cervical cancer affects only women, HPV affects 
both men and women equally. A woman’s risk of contracting HPV infection and 
subsequently developing cervical cancer does not depend on her sexual behavior alone, but 
also on her male partner(s)’ sexual activities, as men are both vectors and carriers of HPV. 
Lack of spousal support, stigma and modesty are social barriers that are beyond the control 
of the woman and require the involvement of men. 
The impact of sociocultural factors, including lack of spousal support, is widely 
recognized as hindering the uptake of cervical cancer preventive measures (Ezeonwu, 
2014; Modibbo et al., 2016). This is not surprising, given that Nigeria is a male-dominated 
society where men are in charge of economies, are the sole family decision-makers, and 
women are subservient to male family members (Ifemeje & Ogugua, 2012; Lim & Ojo, 
2017). Only 15% of Nigerian women have a personal bank account (Council, 2012); only 
one-third of currently married women participate in household decisions; only 40% of 
married women participate in decisions about their own health and 50% do not participate 
in any decisions made in the household (National Population Commission and ICF 
International, 2014).  
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Since the mid-1990s, the importance of involving men in reproductive health 
programs has gained increasing recognition, along with attention to the sociocultural 
factors affecting women’s reproductive health. The World Health Organization (2006) 
recommended involving men in the prevention of cervical cancer in middle and low-
income countries. Studies conducted in developing countries have suggested that lack of 
male involvement may be an overlooked obstacle to cervical cancer screening (Kim et al., 
2012; Lim & Ojo, 2017; Lyimo & Beran, 2012). Men play critical roles in women's abilities 
to seek health care, yet, more often than not, they are uninformed about both their own and 
women's reproductive health needs. Despite the role men play in their partners’ 
reproductive health experiences, HPV and cervical cancer programs in Nigeria have 
focused only on women in reducing the incidence of HPV and cervical cancer; and little 
attention has been devoted to the social factors that expose women to HPV infection, and/or 
hinder them from taking the preventive measures. 
As will be discussed in more detail in Chapter 3, prior research has shown that 
increasing awareness and knowledge of HPV, HPV vaccination, and cervical cancer, and 
cervical cancer screening has been effective in increasing both behavioral intention and 
behavior (Wright, Kuyinu, & Faduyile, 2010; Ndikom, Ofi, Omokhodion, & Adedokun, 
2017). The aim of this research was to implement an educational intervention, delivered 
using two strategies: one that could be efficiently delivered to groups in natural settings 
such as churches, and one that could be delivered to individuals who may not be accessible 
in group settings in order to reach as many people in the target population as possible. 
Members of the target population who are accessible and amenable to a community-based 
group intervention versus a community-based individual intervention likely have 
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meaningfully different sociodemographic characteristics and, possibly, differing baseline 
knowledge and beliefs about HPV, cervical cancer, and the associated risk reduction 
methods.  Thus, the overall purpose of this study is to establish the feasibility of delivering 
group and individual interventions to the target population, and to test the independent 
outcomes of each intervention rather than on comparing the two interventions.   
Study Aims and Research Questions 
The primary aim of this research was to determine the effectiveness of a community-
based educational intervention delivered in groups or to individual men and women living 
in an urban area of southeastern Nigeria. The goal was to increase knowledge of HPV 
infection and cervical cancer, and intention to take and or encourage HPV vaccine and 
screening. Specific research questions were: 
For each community-based educational intervention strategy:  
 What is the level of knowledge of HPV and cervical cancer at post-test versus pre-
test? 
 What is the intention to take and or encourage HPV vaccine and cervical cancer 
screening at post-test versus pre-test? 
 What is the stigma associated with HPV and cervical cancer at post-test versus pre-
test? 
 What variation in knowledge of HPV and cervical cancer were observed among 
participants based on age, marital status and educational level at post-test versus 
pre-test? 
 
 9 
Theoretical Framework: The Theory of Gender and Power (TGP) was selected to 
guide the exploration of male participation in cervical cancer prevention and the need for 
an educational intervention, considering the low awareness, poor knowledge and low 
uptake of HPV vaccine and cervical cancer screening. In addition to TGP, the Precaution 
Adoption Process Model guided the study.  
TGP is a social structural theory that explore the depths of sexual inequity, gender 
and power imbalance (Connell, 1987). Connell identified three major structures that 
characterize the gendered relationships between men and women: the sexual division of 
labor, the sexual division of power, and the structure of cathexis. The three major structures 
are less evident in the institutional level but remain largely intact at the societal level over 
a long period, even as society slowly changes.  
The sexual division of labor refers to occupational differentiation by gender 
(Connell, 1987). Nigerian women are generally assigned to lower paying jobs, positions 
and salaries or relegated to non-income generating labor such as housework, taking care of 
farmland, childrearing, and caring for the dependent member of the family.  This type of 
work does not have assigned economic wages, so women often earn nothing from doing 
them. This makes them financially dependent, relying on men for all their needs; thus, 
constraining women and limiting their economic potential and career paths. These gender-
determined roles and discriminatory practices relegate Nigerian women to domestic work, 
unequal pay for comparable work, prescribed behaviors and expectations, and power 
imbalance within relationships (Ifemeje & Ogugua, 2012).  
The sexual division of power deals with the inequalities in power between men and 
women. This structure at the household level is maintained by social practice, such as 
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through the abuse of authority, control in relationships and marginalization of women 
(Wingood & DiClemente, 2000). Nigerian culture reinforces women to see themselves as 
the lesser gender, be more submissive and subordinate to the male gender (Nnadi, 2013). 
The recent National Population Commission report revealed that only one-third of 
currently married Nigerian women participate in household decisions, and nearly four in 
ten married women participate in decisions about their own health care. Half of the married 
women do not participate in any decisions made in their home (NPC & ICF International, 
2014). Gender power inequality, especially in the form of relationship power imbalances, 
plays a role in sexually transmitted infection (Smith, 2007). 
The structure of cathexis, also referred to as the structure of social norms and 
affective attachment, addresses the affective nature of relationships between men and 
women. It dictates appropriate gender role, the sexual expectations and prescribed 
behaviors of each gender at the societal level. This structure describes the constrained 
expectations the society has for women regarding their sexuality, and consequently, shapes 
their perceptions and limits their experiences of reality.  
The prescribed cultural gender roles limit communication and shared decision 
making among couples especially on sexually related matters (Dunkle et al., 2007). Sexual 
related issues are deemed sensitive and are rarely discussed in most Nigerian communities, 
which often affect communications in marriage, thus hindering women’s expression of self, 
request of what they want and discussion of their reproductive health with their spouses.  
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Figure 1.1: Proposed Modified Theory of Gender and Power 
Methodological Model. The Precaution Adoption Process Model (PAPM) 
explains how a person comes to decisions to take action and how he or she translates that 
decision into action (Weinstein & Sandman, 1992). The adoption of a new behavior or 
precaution or cessation of an unhealthy behavior requires deliberate steps unlikely to occur 
outside of conscious awareness. The model identifies seven stages along the path from lack 
of awareness to maintenance of action over time. Given that this research only focused on 
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knowledge and intention to take HPV vaccine and Pap smear, only the first five stages of 
the PAPM apply. Figure 1.2 illustrates the application of the five stages of the Precaution 
Adoption Process Model to this research, with the aim of increasing the knowledge of HPV 
and cervical cancer, and intention to take HPV vaccine and cervical cancer screening.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Modified Precaution Adoption Process Model 
Stage 1 represents the initial point in time when people become aware of HPV 
infection and cervical cancer. Awareness is the first step to developing an attitude or belief 
about an issue. Individuals who have never heard of HPV infection and cervical cancer, 
cannot have formed opinions or beliefs about the disease or preventive measures. Creating 
awareness on HPV and cervical cancer is vital in building knowledge. Stage 2 represents 
the point at which individuals first receive information or learn about the HPV infection 
and cervical cancer, although they are not yet engaged by this information. Being aware of 
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a disease or its preventive measures increases the possibility of developing an opinion 
about them. However, people will think about an issue or develop an opinion depending 
on the level of awareness or the quality of information known. In terms of this research, 
the educational interventions are designed to both create awareness and provide 
participants with information on HPV, cervical cancer, HPV vaccine and cervical cancer 
screening. The aim is to encourage participants to think about both the disease and the 
available preventive measures. 
Providing adequate information stimulates thoughts about the issue, and people 
begin to consider the issue and have an opinion about it, represented in Stage 3. It is quite 
common for people to be aware of an issue without being personally engaged with the 
issue. When they become engaged, they begin to think of assuming a position. 
Furthermore, people who have a definite position on an issue decide either to take or not 
to take action. The outcomes of Stage 3 (decision making time) will vary depending on 
individual differences. Some people may suspend judgment and remain in stage 3 for some 
time. Others may decide not to take action (Stage 4). Deciding not to take action means 
halting the precaution adoption process at least for the time being. Deciding to take action 
by adopting the precaution is represented in Stage 5. Whichever position an individual 
assumes results in overconfidence in one’s beliefs; searches for evidence to favor one’s 
beliefs, interpretations of data to favor beliefs; and insufficient adjustment of beliefs in 
light of new evidence (Klayman, 1995). One factor that influences people’s decision 
regarding HPV vaccination is perceived susceptibility (Connor & Norman, 1995). The aim 
of the educational interventions was to enhance participants’ recognition of their or their 
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family members’ susceptibility to HPV infection and cervical cancer risk. The following 
chapter contains the research plan.  
Overview of Manuscripts and Target Journals 
This dissertation is organized in the manuscript format.  The aim of this research 
was to assess if a community-based educational intervention delivered to men and women 
living in an urban area of Nigeria would increase the knowledge of HPV infection and 
cervical cancer, increase intention to take HPV vaccine and screening, and reduce stigma 
about HPV infection and cervical cancer. The community-based health education 
intervention included participants who received a face-to-face presentation on HPV 
infection, cervical cancer, HPV vaccination and cervical cancer screening (Presentation 
Group) and individual participants who read a pamphlet containing similar information 
(Pamphlet Group). A total of 281 men and women between the age of 18 and 65 years who 
could- read and write in English and resided in Anambra state participated in the study. 
The survey instrument, a self-administered survey, was given to the participants before and 
after the intervention.  
Data analysis consisting of descriptive statistics (frequency and percentage) 
inferential statistics (T-test, Chi-square and logistic regression) were done using Statistical 
Analysis System (SAS) software. This study is significant in many ways and has 
importance to diverse audiences. The findings from this study may assist governments and 
Non-governmental organizations in planning interventions to increase HPV vaccination 
and cervical cancer screening in Nigeria. In addition, program planners and researchers 
may build on the findings or use the findings to guide future research on HPV and cervical 
cancer.  
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The first manuscript is a scoping review of male participation in reproductive health 
interventions in sub-Sahara Africa. The manuscript emphasizes men’s shared 
responsibility and active involvement in sexual and reproductive behavior as an important 
step in improving reproductive and maternal health. The review synthesis examined and 
describes the outcome of men’s participation in various reproductive health programs such 
as family planning, birth preparedness, dual protection from HIV/sexually transmitted 
infections (STI), and maternal health service utilization carried out between 2007 and 2018 
in Sub-Sahara Africa. This manuscript has been submitted to the International Perspective 
on Sexual and Reproductive Health Journal.  
The next two manuscripts describe the effectiveness of the community-based health 
education intervention in improving knowledge of HPV and cervical cancer, increasing 
intention to take HPV vaccine and cervical screening and reducing HPV and cervical 
cancer stigma among men and women in Nigeria. The first manuscript details the changes 
in awareness, knowledge and intention to take to HPV vaccination and cervical cancer 
screening before and after the educational intervention. (Chapter 3). The manuscript will 
be submitted to the International Journal of Public Health. The second manuscript describes 
an evaluation of educational intervention to reduce stigma associated HPV and Cervical 
cancer in Nigeria. The target journal for this manuscript is the Global Public Health 
Journal. 
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CHAPTER 2 
MALE PARTICIPATION IN REPRODUCTIVE HEALTH INTERVENTIONS IN 
SUB-SAHARAN AFRICA: A SCOPING REVIEW  
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Background 
Over the past two decades, there has been only minimal improvement in women’s 
reproductive health indicators in the African region (WHO, 2014). Reproductive and 
sexual health problems represent one-third of the total global burden of disease for women 
between the ages of 15 and 44 (WHO, 2013). Maternal mortality rates in the region are 
among the highest in the world, with nearly half of the estimated 830 daily maternal deaths 
occurring in sub-Saharan (Alkema et al., 2016). Hypertension during pregnancy (e.g., pre-
eclampsia and eclampsia), complications from delivery, unsafe/unattended abortion, and 
postpartum hemorrhage and infections account for nearly 73% of all maternal deaths 
worldwide (Say et al., 2014). Over the past 20 years, the maternal mortality rate in Africa 
has declined only 2.7%, yet the maternal mortality rate needs to continue to decline at least 
5.5% per year in order to reach the Millennium Development Goal 5 of universal access to 
reproductive health with a 75% reduction in the maternal mortality rate and in the African 
region (WHO, United Nations Department of Public Information [UNICEF], United 
Nations Children's Fund [UNFPA], The World Bank, 2012). Given that between 1990 and 
2010 the total rate of decline was only 2.7%, it is clear that persistent challenges to 
improved maternal health are not being adequately addressed.   
Persistent gender, social and ethnic disparities continue to inhibit progress in 
women’s health across the globe (International Conference on Population and 
Development [ICPD], 2014). In Sub-Sahara Africa, gendered cultural beliefs and practices, 
and limited access, affordability, and utilization of health facilities contribute to women’s 
health disparities. Culturally, men are the decision makers and gatekeepers in most African 
families and therefore hold power and influence over decisions regarding women’s access 
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to health services, contraception and prevention of sexually transmitted infections (STI). 
Furthermore, men often control the allocation of money, transportation, time and 
permission women need to access health services.   
The importance of involving men in reproductive health programs has gained 
increasing recognition since the mid-1990s, and there is increasing recognition that men’s 
participation in reproductive and sexual health is an important step in supporting women’s 
health and improving family health. Formally recognized at the 1994 International 
Conference on Population and Development, at the 1995 Women's International 
Conference in Beijing,  three avenues for men’s active inclusion and shared responsibility 
in women’s health were identified: (1) promoting men’s use of contraceptives through 
increased education and distribution; (2) involving men in roles supportive of women’s 
sexual and reproductive decisions; and (3) encouraging men to indulge in responsible 
sexual and reproductive practices to prevent and control STIs (United Nations Department 
of Public Information, 1995;  UNFPA, 2004).  
Researchers have explored the importance of men’s involvement in women’s 
decision-making and use of reproductive health services in Sub-Sahara Africa in various 
studies using a wide range of research designs and methods. An assessment of women’s 
sex preference, decision making and fertility control in the Ekpoma community in south 
southern Nigeria showed that more than half of the women believed it is the man’s right to 
make the final decisions in the home including reproductive decisions (Agatha, Sims, & 
Godfrey, 2007). Similarly, an examination of the motivations and preferences of rural 
Nigerian women undergoing cervical cancer screening indicated the most frequently 
reported motivating factors of women’s participation in cervical cancer screening were the 
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support and opinion of her husband and the community leaders (Chigbu, Onyebuchi, Ajah, 
& Onwudiwe, 2013). Not surprising, in studies conducted in both Burkina Faso Sawadogo, 
Gitta, Rutebemberwa, Sawadogo, & Meda, 2014) and Nigeria (Ezeonwu, 2014; Modibbo, 
2016), lack of spousal support was identified as one of the reasons for women not being 
screened for cervical cancer.  
Recognizing the sociocultural factors exposing women to a higher risk of 
contracting sexual transmitted infections, the Joint United Nations Programme on 
HIV/AIDS (UNAIDS, 2010) called for development and implementation of innovative 
strategies to further educate men about women’s health. To further strengthen and promote 
the recommendation of male involvement in reproductive health interventions, it is 
imperative to examine the impact of male involvement in reproductive health interventions 
(family planning, sexual risk behaviors, antenatal care, birth preparedness, maternal 
health). Reproductive health program planners and researchers have employed various 
interventions involving men in an effort to improve reproductive health and increase the 
utilization of reproductive health services. Examples include invitation letters, home visits, 
community events and use of community health workers. The previously published 
reviews on male participation in women’s health issues in Sub-Sahara Africa focus on 
prevention of mother-to-child transmission of HIV, HIV counselling and testing, HIV 
reduction barriers and facilitators as opposed to interventions to improve reproductive 
health (Auvinen, Kylma, & Suominen, 2013; Burton, Darbes, & Operario, 2010; Hensen, 
Taoka, Lewis, Weiss, & Hargreaves, 2014; Morfaw, et al., 2013). The specific aim of this 
scoping review was to examine evidence published between 2007 and 2018 related to 
evaluation of reproductive health interventions that involved men in efforts to improve 
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reproductive and maternal health in Sub-Sahara Africa from 2007 to 2018.  This review is 
of interest to health care providers, researchers and public health planners concerned with 
reproductive health issues, particularly among women in Sub-Saharan Africa, but also in 
other regions of the globe.  
Methods  
 We conducted multiple searches through Google Scholar, PubMed, Science Direct, 
Medline, Global Health, PsycInfo and Cumulative Index to Nursing and Allied Health 
Literature. Search terms were related to male involvement (i.e., male, men, spouse, couple, 
involvement, participation, engagement, program, trials, spouse; couple) in reproductive 
health issues (i.e., family planning, sexual risk behaviors, antenatal care, birth 
preparedness, maternal health, reproductive health, maternal health, sexual health; family 
planning; antenatal care, condom use, birth preparedness) in Sub-Sahara Africa (i.e., 
Nigeria, Malawi, Ethiopia, Tanzania). Once retrieved, articles were further screened using 
the following inclusion criteria: (1) articles published in English between January 2007 and 
March 2018; (2) reports of reproductive health interventions involving men in Sub-Saharan 
Africa; and (4) reports of research that employed an experimental or quasi-experimental 
study design. Subsequent to the identification of relevant sources, the reference list of each 
identified article was reviewed to identify additional eligible studies (three articles were 
included). Excluded were reports of programs that only addressed prevention of mother-
to-child transmission of HIV and HIV counselling and testing.  
The initial electronic bibliographic search yielded titles of 2,847 articles, including 
1,313 duplicates which were subsequently excluded. An examination of the titles of the 
remaining 1,534 articles resulted in further exclusion of 1,275, yielding a sample of 259 
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research reports that met the inclusion criteria for full-text review. Of these, 18 articles met 
the criteria and were submitted to independent review by a second independent examiner, 
who independently examined all 18 full texts and confirmed all manuscripts met the 
inclusion criteria. Subsequently, the following information from each study was entered 
into a Microsoft Excel database: title, authors, publication date, intervention-publication 
interval, sample characteristics, location, study design, type of reproductive and/or 
maternal health program, data collection method(s), comparison group, outcome measures, 
intervention characteristics (i.e., number and types of intervention strategies,  outcome 
measures), and intervention strategies (i.e., individual or couple-based approaches). One 
person extracted, and both reviewed; and reviewers discussed any disagreements in the 
data extracted.   
Results 
The final sample consisted of 18 interventions articles were published between 
2007 and 2018, each of which included an evaluation of men’s involvement in a 
reproductive health intervention in Sub-Saharan Africa. The articles included research 
conducted in Nigeria (n=6), Malawi (n=5), Tanzania (n=3), Uganda (n=2), Ethiopia (n=1), 
Senegal (n=1), Kenya (n=1) and Mozambique (n=1). Couples, men living with female 
partners, and men only were the most common target group (17); one study involved only 
women with information focused on men and encouraged women to deliver the 
information. The majority of the participants were 18 years of age and above, although six 
studies included participants as young as 14 and 15 years. The reproductive health outcome 
measures were family planning (n=9), maternal health/service utilization (n=8), HIV 
counselling and testing (n=4), birth preparedness (n=1), dual protection from HIV/STI 
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(n=1) and uptake and adherence of antiretroviral therapy (n=1). The research designs 
included surveys, interviews and focus groups. Five studies included a theory-based 
intervention to assess impact of male involvement in reproductive health (Adeleye & 
Okonkwo, 2016; Adeleye, Aldoory, & Parakoyi, 2011; Exner et al., 2009; and Hartmann 
et al., 2012; Shattuck, et al., 2011).  Overall, the study designs reported in the articles were 
12 quantitative, 1 qualitative, and 5 mixed methods studies.   
Intervention Theoretical Framework and Design 
 The most common theoretical frameworks were Gender Theory and the 
Information-Motivation-Behavioral Skills Model. Adeleye & Okonkwo, (2016) and 
Adeleye, Aldoory, & Parakoyi, (2011) employed the Gender Theory to explore maternal 
health services utilization. Gender Theory posits that gender constitutes the social, 
economic, and political contexts that guide particular beliefs, norms, and behaviors. In their 
research conducted in Malawi, Shattuck, et al., (2011) and Hartmann et al., (2012) 
employed the Information-Motivation-Behavioral skills model which postulates that 
health-related information, motivation, and behavioral skills are important determinants of 
whether a family planning behavior is performed. Exner et al., (2009) used the Stages of 
Change Model to guide the intervention to promote dual protection against HIV/STI.  
In terms of research design, there were three randomized controlled trials (RCTs), 
eleven studies that employed a pretest/posttest design and four studies that were posttest-
only. Furthermore, eight studies had a comparison group and fifteen studies used at least 
three intervention strategies. In this review, 10 studies were couple-based interventions, 
seven studies targeted only men and one study targeted only women. The couple-based 
interventions were focused on family planning, HIV counselling and testing and maternal 
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health services utilization.  The studies that targeted only men explored HIV/STI dual 
protection, maternal health services utilization, birth preparedness and family planning.  
Interestingly, one study had only women as the study participants, and the purpose was to 
assess the women’s perspectives about the impact a maternal health mass media campaign 
had on their husbands. Almost all the studies assessed the impact of male involvement in 
marriage relationships and/or co-habiting relationships. Nine studies were conducted in 
urban settings, eight studies were conducted in rural settings and one study involved 
participants residing in both urban and rural settings. 
Intervention Content and Outcomes 
Uptake of family planning services was the primary outcome measure in the 
majority of the studies (n=9), followed by maternal health service utilization (n=6). 
Collectively, these studies indicated that inclusion of men in reproductive health 
interventions is an essential component of effective reproductive health interventions in 
Sub-Saharan African. 
Men’s Willingness to Participate 
Studies conducted in Nigeria, Ethiopia, and Uganda evaluated men’s willingness 
to participate and complete the reproductive health programs. The reports indicated high 
participation and retention among their participants.  The use of local culture and gender 
roles to improve men’s involvement in maternal health, Adeleye, Aldoory, and Parakoyi, 
(2011) reported that about 90% of the participants attended nine group health talks which 
averaged 2 hours in duration and were conducted over in 4-week period in Nigeria. In 
similar study in Nigeria, more than 90% of the respondents had attended a two-hour 
educational session on maternal death (Adeleye, Aldoory, & Parakoyi, 2011). Exner and 
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colleagues (2009) observed that the majority (91 %) of the men who participated in a 
program to increase dual protection against HIV/STI attended two five-hour sessions 
scheduled one week apart, and 75% attended both monthly two-hour ‘check-in’ sessions 
post-intervention (Exner et al., 2009).  
Furthermore, among couples who participated in a family planning intervention 
aimed at encouraging spousal communication, 92% of the couples responded to face-to-
face discussions (Tilahun, Coene, Temmerman, & Degomme, 2015). Similarly, 
Ghanotakis and colleagues (2016) reported 65% of male participants attended all 10 
sessions focused on transforming gender norms and encouraging uptake of family planning 
and HIV services. Interestingly, nearly all participants reported complete trust in the 
credibility of the information shared and high satisfaction with the workshop. These 
findings challenge the conventional assumptions and stereotypical perceptions that most 
African men are not interested in participating in programs involving women’s health and 
healthcare services (Chipeta, Chimwaza, & Kalilani-Phiri, 2010; Olawoye et al., 2005). 
These findings clearly suggest African men are willing to participate in reproductive health 
programs, either individually or with their partner/spouse and provide further support for 
the notion that providers, researchers and program planners should be attentive and actively 
respond to opportunities to include men in reproductive health programs and services.  
Couple-Oriented Interventions 
There were ten examples of reproductive health interventions designed for married 
or co-habituating partners.  The focus of these interventions was either family planning 
uptake (Hartmann, Gilles, Shattuck, Kerner, & Guest, 2012; Shattuck, et al., 2011; Tilahun, 
Coene, Temmerman, & Degomme, 2015; Becker, et al., 2014; Lemani, et al., 2017) or 
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maternal health (i.e., obstetric care, antenatal care, skilled birth attendance) alone or with 
HIV counselling and testing and or gender norm transformation (Jefferys, et al., 2015; 
Byamugisha, et al., 2011; Bright, et al., 2015; August, Pembe, Mpembeni, Axemo, & Darj, 
2016; Mushi, Mpembeni, & Jahn, 2010). Intervention contents namely, education, 
counseling, behavioral skills, home visits, follow-up visits and community events were all 
efficacious strategies that resulted in positive outcomes.  
Further, community-engaged and collaborative approaches such as community-
based participatory research (CBPR) were defining characteristics of these programs to 
generate meaningful outcomes. Trained community health workers (CHWs) were used in 
six studies, to provide the community interventions (Hartmann, Gilles, Shattuck, Kerner, 
& Guest, 2012; Becker, et al., 2014; Lemani, et al., 2017; August, Pembe, Mpembeni, 
Axemo, & Darj, 2016; Mushi, Mpembeni, & Jahn, 2010; Audet, et al., 2016). In these 
instances, CHWs were members of the local community, without formal professional 
health training. They were referred to by a variety of terms, including promoters, 
traditional birth attendants, male champions, community health counselors, community 
agents, lay providers, and peer support specialists. For example, August and colleagues 
employed and trained trusted men and women who had completed primary school and 
could read and write in the villages to identify pregnant women in the community and make 
at least four visits to the family throughout the pregnancy (August et al, 2016). Similarly, 
health surveillance assistants, stratified by sex and catchment area, visited women from 
their catchment areas in their homes and counseled them on family planning alone and with 
the male partner. The Health Surveillance Assistants (HSA) would then initiate the family 
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planning method of the woman’s choice if the woman asked for a short-term method or 
refer her to the nearest facility for long-term family planning methods (Lemani et al, 2017) 
Utilization of community-based approaches to health promotion and prevention 
may reduce the challenges of standard research approaches, strengthen the rigor and utility 
of science for community applicability, enhance evidence-based translation to local 
communities, and demonstrate both individual and community benefit (Horowitz, 
Robinson, & Seifer, 2009). For example, Audet and colleagues (2016) conducted a 
community participatory action program in Mozambique that integrated and deployed 
CHWs to the community to engage men in prenatal care services and increase HIV testing 
and treatment uptake. The CHWs established a male-friendly clinical environment and 
provided couples counseling sessions. The CHW intervention increased male 
accompaniment at antenatal care appointments, HIV testing among pregnant woman, male 
partner presence at antenatal visits, maternal attendance at a minimum of three antenatal 
appointments, and slight decreased median gestational age at first antenatal care visit. 
Partner accompaniment to antenatal care was associated with higher odds of health facility 
delivery, but little difference in odds of anti-retroviral treatment initiation (Audet et al., 
2016).  
Benefits of CHW engagement include their familiarity with local issues, existing 
rapport with community members, and circumvent the problem of a scarcity of other 
human resources. Becker and colleagues (2014) reported on the utilization of a pair of 
CHWs in Malawi to provide family planning and or HIV counseling and testing in a single 
home visit to couples. They reported that more than 75% of the women and men visited by 
CHWs subsequently received their first HIV test and about 60% of couples tested 
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subsequently reported they discussed the results of their HIV test as a couple. The results 
also indicated a significant increase in condom use during the most recent sexual 
intercourse, and there were no reported incidents of serious violence among any of the 
couples at the one-week follow-up visit. In a similar study in Malawi, women who received 
couples counseling training were more likely to have their partners present during 
subsequent counseling and to receive condoms at their first family planning visit (Lemani 
et al., 2017).  
Other reported outcomes of CHW interventions include improved community 
perception, acceptability and utilization of obstetric care among couples (Mushi et al. 
2010). Mushi and colleagues used community-based safe motherhood promoters to 
improve the utilization of obstetric care in a rural district of Tanzania. Findings included a 
significant increase in early antenatal booking by primigravida mothers, in the number or 
primigravida women attending at least one antenatal visits and in the proportion of women 
who delivered with skilled attendants. In addition to antenatal care attendance at least once 
during pregnancy by all the women, the number of respondents who were able to mention 
at least three pregnancy risk factors and cite at least three practices that contribute to delay 
in seeking obstetric care increased signficantly (Mushi et al. 2010). In Tanzania, CHWs 
delivered a Home-Based Life Saving Skills training for pregnant women. The CHWs made 
a minimum of four visits to the family during the period of the woman’s pregnancy. 
Women who received the CHW visits had increased levels of knowledge of potential 
danger signs during pregnancy, childbirth, and postpartum. Also, a higher proportion of 
men accompanied their partner/wives to prenatal care visits and a higher proportion of 
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women were involved in shared decision-making about place of delivery (August et al., 
2016).  
Given that CHWs are trained to provide the culturally and context‐specific 
advocacy and engage in the reciprocal exchange of information within familial social 
contexts, these findings are not surprising. CHWs serve as vital links, bridges, and in‐
between people, brokering between the world in which they and their neighbors live and 
the healthcare system (Norris et al., 2006). Similar results were reported in CHW-delivered 
family planning intervention studies in Malawi and in Ethiopia. A Randomized Controlled 
Trial on couples’ family planning communication in Malawi used five visits to provide 
information, motivation, and behavioral skills to intervention group particpants.  The 
intervention was delivered by a male motivator over 6 months. As compared to the control 
group, intervention group participants reported a significant increase in contraceptive use, 
in ease and frequency of discussing family planning with their partners, the use of joint 
process for deciding to use family planning, and reduced differential couple 
communication (Hartmann et al., 2012). The authors added that the frequency with which 
men discussed family planning with their wives was a significant predictor of family 
planning uptake. Tilahun and colleagues (2015) measured spousal communication and 
family planning uptake among couples in Ethiopia. They reported a positive association 
between the intervention and use of contraception among those who were not using 
contraceptives at baseline, and higher levels of husbands’ involvement and spousal 
discussion on family planning. However, no significant difference in contraceptive use was 
found between the intervention and control arms. These findings provide further evidence 
that CHWs programs may be more successful in community‐based, participatory models, 
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in which community members and healthcare and other agencies have shared values, 
equity, planning and participation (Norris et al., 2006). 
In all ten of these studies, regardless of the type of reproductive health program, 
intervention strategy, or duration of intervention, male involvement in couples-orientated 
programs was efficacious. Three studies employed formal written invitation letters to 
incentivize male participation in women’s reproductive health (Jeffreys et al., 2015; 
Byamugisha1 et al., 2011; Bright et al., 2011). In Tanzania, Jeffreys and colleagues (2015) 
used written invitations to motivate male partners to attend joint antenatal care and couple 
voluntary counselling and testing. They reported 81% of the couples that attended a joint 
antenatal care session received voluntary couple counselling and testing, and 71% reported 
an improved relationship between with their partner. Beyond improved couple 
communication and support, 96% of the women noted improved decision-making 
regarding antenatal care, family planning and sexual and reproductive health (Jeffreys et 
al, 2015).  
Similarly, in Uganda, Byamugisha and colleagues (2011) reported the positive 
effect of written invitation letter on couple antenatal attendance and partner acceptance of 
HIV testing. More than 90% of males who attended the antenatal clinic visit with their 
wives accepted HIV counselling and testing. Similarly, in Nigeria, male partners of 
antenatal attendees who accepted an invitation to be part of a three-day participatory 
training on female reproductive health and family planning showed a remarkable increase 
(90%) in knowledge of methods of contraception and a higher proportion of men who 
expressed intent to use family planning in the future. At follow-up with 50 couples, all 
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male participants reported improved spousal communication on family planning (Bright et 
al., 2015).  
Interventions designed for men-only  
There were seven examples of interventions delivered exclusively to men, without 
the presence of partners or spouses (Adeleye, Aldoory & Parakoyi, 2011; Exner et al., 
2009; Ghanotakis et al., 2016; Shattuck et al., 2011; Adeleye & Okonkwo, 2016; Okigbo, 
Speizer, Corroon, & Gueye, 2015). The content of these programs included family 
planning, birth preparedness, dual protection from HIV/STI, and maternal health 
improvement. Assessment of these interventions examined the level of men’s participation, 
their adoption of the specific intervention, and level of spousal influence on the adoption 
of the intervention by their wives. Various approaches to engage men were employed, 
including peer-delivered interventions, male-friendly clinics, and active engagement of 
community leaders. There is increasing recognition of the power and influence of peer 
education in health promotion and illness prevention.  
Peer-delivered educational interventions are important to involve and engage men 
in reproductive health initiatives given the complex nature of relationships and societal 
pressures.  The reported peer-led interventions resulted in greater positive changes in 
contraceptive uptake, and HIV service uptake. For example, post-assessment of a peer-
delivered educational intervention designed to encourage contraceptive use among 
Malawian men and to foster communication about family planning with their partners, 
demonstrated a significant increase (78%) in male intent to use family-planning methods 
among men in the intervention arm compared to 59% in the of the comparison arm.  
Additionally, a significant increase using family-planning methods with their wife and 
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intended to continue for 2 years; and overall communication about family planning with 
their partner (Shattuck et al, 2011).  
Similarly, in Uganda, peer educators delivered a community-based intervention to 
improve family planning, HIV service uptake, and transform harmful gender norms 
(Ghanotakis et al., 2016). Men who received the intervention reported higher levels of 
seeking clinic services for self, condom use with main partners over the past three months, 
having an HIV test, communicating with main partners on family planning method, and 
accompanying a partner to the clinic in the past five months (Ghanotakis et al., 2016). 
Given the wide recognition of peer education as an approach in communicating behavioral 
changes especially in addressing HIV pandemic, these findings are not surprising (Harris, 
Smith & Myer, 2000). Furthermore, health education and outreach by peers, community 
health workers, and local community and religious leaders are cost-effective community 
health promotion strategies that utilize local human resources.  
Community and religious leaders are vital community members in Sub-Sahara 
Africa, where collectivism is a way of living and community leaders’ opinions are an 
important factor in women’s utilization of health services (Chigbu, et al., 2013). These 
leaders are key stakeholders who can effect changes through advocacy, effective 
mentorship, policy change, and seeking the support of benevolent community members 
and organizations to improve community resources. Male community leaders in Nigeria 
were motivated to act as change agents and encouraged other men to assist with maternal 
health in their community after being engaged in group health talks to improve maternal 
health (Adeleye, Aldoory, & Parakoyi, 2011). Okigbo and colleagues (2015) reported 
similar findings in their assessment of a family planning program that was positively 
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associated with men reporting increased use of modern contraception in Kenya, Nigeria 
and Senegal. The program involved religious leaders in television programs, print media, 
and community events aimed at increasing men’s exposure to family planning messages 
and modern contraceptive use. 
Furthermore, Nigerian men who had female partners were mobilized to increase 
dual protection against HIV/STI, which produced notable outcomes. The participants were 
one-third less likely to engage in unprotected sex in the prior 3 months, approximately four 
times more likely to report condom use at last sexual intercourse with their main partner, 
and approximately seven times more likely to correctly identifying venues for HIV testing. 
Additional outcomes included: men’s partners were 10 times more likely to have been 
tested for HIV/STI, the men had lower expectations that condoms would be associated with 
a negative response in the context of their primary relationship, and the men held 
significantly less stigmatized beliefs about HIV-infected people (Exner et al., 2009).  
Male engagement in healthy sexual behaviors is essential to ensure the sexual and 
reproductive health of women, girls, and families. Men are increasingly encouraged to 
participate in improving maternal health because of their role as family gatekeepers.  An 
educational session on maternal deaths among married men in Nigeria showed large 
improvement in their knowledge of family planning methods for females, facilities for 
antenatal care and delivery, and key warning signs of maternal death (Adeleye & 
Okonkwo, 2016). Additionally, there was increased willingness to provide money and 
encourage partners to seek care. One of the key strategies to reduce maternal death and 
increase safe motherhood is birth preparedness (Acharya, Kaur, Prasuna, & Rasheed, 
2015). Birth preparedness includes knowing danger signs, planning for a birth attendant 
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and birth location, arranging transportation, identifying a blood donor, and saving money 
in case of an obstetric complication (Acharya, Kaur, Prasuna, & Rasheed, 2015). Although, 
Ibrahim et al., (2014) reported that a behavioral intervention had no statistically significant 
impact in the levels of birth preparedness among married men in Nigeria, they did observe 
other positive behavioral changes among husbands who participated. These behavioral 
changes included: encouraging their wives to attend antenatal clinic, accompanying their 
wives to the clinic, reducing their wives’ household chores, taking care of their wives’ 
basic needs, granting their wives permission to seek health care when ill, taking their wives 
to the health facility when ill, donating blood when it was needed, and regularly providing 
traditional medicine for their wives (Ibrahim et al., 2014).  
It is important to note that one way to reach men is to provide strong encouragement 
for women to share key health messages and information with their partners. Indirect 
involvement of men may be a way to enhance maternal health in Africa. For example, 
Zamawe, Banda, and Dube (2015) assessed the impact of a maternal health mass media 
campaign aired in Malawi and found a significant relationship between women’s exposure 
to the radio campaign and an increased likelihood that their husbands were involved in 
maternal health issues, including participating in antenatal care, being involved in 
childbirth and participating in postnatal care.   
Discussion 
  This review presents the current state of the science related to male involvement 
in reproductive health interventions in Sub-Saharan Africa from 2007 to 2018. The salient 
findings indicated male involvement is a feasible and effective strategy for improving 
family planning usage, utilizing maternal health services, participating in HIV counselling 
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and testing, changing some harmful gender-based norms, and reducing risky sexual 
behaviors. There is clear evidence from the existing research that male community and 
religious leaders are willing to be advocates and change agents and involved in women’s 
health issues. Therefore, it is important that reproductive health programs are adapted to 
and organized in line with the community local culture to enhance acceptance, adoption 
and utilization. In most Sub-Saharan nations, individuals are strongly engrained in social 
and cultural practices, norms, and expectations, which limits control and freedom for self-
expression, requiring submissiveness, especially from women and girls. This gender power 
inequality plays a role in sexual and reproductive health. 
 The findings from this review showed that men are willing to participate in 
reproductive health programs, which contradicts the stereotypically assumptions and 
perception that African men are often uninterested in reproductive health and that 
reproductive health responsibilities are solely the role of a woman (Chipeta, Chimwaza & 
Kalilani-Phiri, 2010). Men are important partners in reproductive health, considering the 
increasing emphasis on social determinants of health. The socio-cultural factors, especially 
in relation to gender inequality, in developing countries makes this review very vital for 
health providers, program planners and health organizations to be actively engaged in 
creating and sustaining initiatives to include men in women’s health promotion. Based on 
the literature analyzed, increased and enhanced male participation will support women’s 
health choices and encourage shared decision making.  
This analysis showed that irrespective of the duration of intervention, involving 
men in various reproductive health programs is an important strategy in improving family 
planning knowledge and uptake, HIV knowledge, counselling and testing, maternal health 
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services use, spousal communication. In addition, involving men in reproductive health 
programs reduced risky sexual behaviors and lessened their beliefs and reported behaviors 
some harmful gender-based norms. The increased positive outcomes observed in this 
analysis may be due to increased willingness and participation among the participants 
which potential explains the improved retention of key messages, increased acquisition of 
behavioral skills, increased communication among partners/couples and increased men’s 
accompaniment. Increased knowledge about sexual health is associated with attitude 
changes, which have been shown to influence behavior and practice (Davidson et al. 1985). 
These findings corroborate others’ reports that providing men with information on healthy 
maternal and reproductive health practices may encourage both the men and women to 
adopt the behaviors, increase use of services, and support partners’ choices (Onyango, 
Owoko, & Oguttu, 2010; Steinfeld et al., 2013; Wambui, Ek, & Alehagen, 2009).  
Furthermore, there is clear evidence that the mobilization of men as partners in 
reproductive health is very vital in reducing the spread of sexually transmitted infections. 
Men who participated in the HIV/STI interventions were more likely to have higher safe 
sex self-efficacy, use condoms and be tested for HIV/STIs. This review is especially 
pertinent in Sub-Saharan Africa, where evidence suggests that many women are 
contracting STIs such as HIV within the context of their primary relationships (Hirsch, et 
al., 2007). The observed changes could be due to increased knowledge of the risk of unsafe 
sexual practices on men and their partners and changes in attitude. The degree to which 
these male participation interventions improved reproductive health depended on many 
factors such as the number and type(s) of interventions implemented, the implementation 
strategies, the quality of implementation, the type of outcome indicator(s) and the outcome 
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measures. As observed in this review, increased contact is very important in increasing the 
effectiveness of reproductive health interventions as almost all the studies had at least three 
contacts with the participants, which were mostly the initial contact, continuing visits and 
follow up contact. This is in line with the recommendation by WHO (2003).   
This review highlights the fact that male involvement can be enhanced through 
home-based intervention delivery, friendly facility-based service delivery, and engagement 
with trained CHWs. It is well known that CHW engagement and the provision of home-
based services are effective strategies to expand coverage and increase accessibility and 
availability of services to people living in resource–constrained areas (Mushi et al., 2010; 
Audet et al., 2016). These approaches are necessary in Sub-Sahara Africa, where a large 
proportion of the low-income populations live more than one hour away from a health 
facility (Pearson & Shoo, 2005). This finding corroborates other studies that used trained 
CHWs to improve maternal health outcomes (Homer et al., 2014; Lane & Garrod, 2016).  
It is important to note that findings from this review suggest that men’s involvement 
may not significantly impact certain indicators of reproductive health interventions, such 
as birth preparedness, and widespread gender-based norms (i.e., equal decision-making 
power) in Sub-Saharan Africa. Interestingly, regardless of the lack of significant difference 
with the primary outcome measures reported in few of the studies, there were positive 
changes in other contributing factors like freedom to access care, increased spousal 
communication and financial and emotional support. Several confounding factors may 
inhibit the outcome of an intervention, which may not have been considered during the 
planning phase. These include the type of marriage/relationship, educational levels, 
financial capabilities of individuals, families, and communities, and religious beliefs. For 
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example, a clear evidence of religious barriers to male involvement in birth preparedness 
was observed by Ibrahim and colleagues (2014). In addition, polygamous marriages or 
non-cohabiting relationships may contribute to limited success of birth preparedness as 
men in these contexts may have competing needs or be less engaged with expectant 
mothers. The lack of significant effects on birth preparedness may also be a consequence 
of lack of spousal communication and lack of couples’ joint antenatal attendance, thus 
resulting in limited exposure of men and women to the benefit of birth preparedness. These 
findings suggest that others socio-demographic barriers must be considered when 
involving men in interventions to promote birth preparedness. 
This review corroborates other calls for the recognition of the importance of men’s 
involvement in reproductive health, especially in developing nations. Given the evidence 
that men’s involvement in reproductive health programs contributes to positive health and 
social impacts, it is important to create and implement specific strategies aimed at 
enhancing the involvement of both men and women in reproductive and family health 
initiatives and in informing policy recommendations and programmatic planning to 
improve reproductive health in Sub-Saharan Africa.  
Limitations and Recommendations 
To our knowledge, this is the first review to examine the effects of male partners 
participation in reproductive health interventions in Sub-Sahara Africa and therefore is an 
important contribution to the literature. These findings are limited to the available literature 
accessible through major search engines within the past eleven years (2007 – 2018). Other 
limitations include the exclusion of all literature published in languages other than English 
and research that did not employ an experimental design. The decision to exclude non-
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experimental designs reflected the aim of exploring the impact of men’s engagement in 
reproductive health issues. Thus, the review is restricted to an assessment of men’s 
participation in reproductive health.  Another potential limitation is that a single author 
reviewed the individual papers for inclusion into the review.  
These findings do provide the basis for several recommendation for future research 
on male involvement in reproductive health in Africa and in developing nations. Further 
research on male knowledge, attitudes, and involvement in reproductive health issues and 
interventions within Sub-Sahara Africa clearly is warranted. Further research is needed to 
support scale up of the best practices for involving men in further reproductive health. 
Other area for further research include the assessment of specific mechanisms aimed at 
enhancing male participation in reproductive health initiatives.   
Conclusion 
The evidence provided in this review clearly supports the recommendation that 
involving men in reproductive health is essential to improving the health of women, men, 
and families in Sub-Sahara Africa. There is clear evidence of the individual, family, and 
community benefits of involving African men in reproductive health programs and 
services. Involving men should not be limited to reproductive health programs and services 
but also incorporated into efforts related to cervical cancer prevention, poverty alleviation, 
and infant/child nutrition. Reproductive health programs should be gender comprehensive 
and context-specific by bringing men to the table as equal partners rather than considering 
their presence as a barrier. More research is warranted to support and strengthen the 
findings of this review and to build evidence to support the sustainability and scaling-up 
of male participation interventions in various health programs.  
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CHAPTER 3 
EFFECT OF A COMMUNITY-BASED EDUCATIONAL INTERVENTION ON 
AWARENESS, KNOWLEDGE AND INTENTION TO TAKE HPV VACCINATION 
AND CERVICAL CANCER SCREENING IN NIGERIA. 
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Introduction 
Worldwide, human papillomavirus (HPV) infection is the most common sexually 
transmitted viral infection of the reproductive tract. HPV infection is so common that the 
majority of sexually active men and women will be infected with at least one type of HPV 
at some point and may have recurrent infections (Center for Disease Control [CDC], 2017). 
Globally, the prevalence of HPV infection in women is 11–12%, with a much higher rate 
of 24% in Sub-Saharan Africa (Forman, et al., 2012). At least 20% of women with normal 
cervical cytology in Sub-Saharan Africa are infected with carcinogenic HPV genotypes 
(De Vuyst et al., 2013).  Nigeria is among the Sub-Saharan nations with high rates of HPV-
related diseases (Bruni, et al., 2018). Although there are currently no specific estimates of 
HPV prevalence among the general population in Nigeria, available data from various 
studies conducted in different cities and states indicate a high prevalence of HPV among 
women. For example, a seroprevalence of 42.9% for IgG antibodies to HPV was reported 
among women attending the reproductive health clinic in Zaria, a city in the northern 
region (Aminu et al., 2014). Other researchers reported HPV infection rates of 30.4% and 
36.5% among women who attended the outpatient clinics of a university teaching hospital 
in Lagos, South-West Nigeria (Adegbesan-Omilabu, 2014; Okunade, et al., 2017).  
Clinical challenges to identifying and tracking HPV infection include the fact that 
it is difficult to detect the point at which an individual first became infected with HPV due 
to the fact that the infection is asymptomatic, and symptoms often only develop many years 
following initial infection (CDC, 2017). Although most HPV infections will clear without 
medical intervention, individuals who contract persistent high-risk HPV types may 
eventually develop cancer (CDC, 2017). Cervical cancer is by far the most common HPV-
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related cancer, as nearly all cases of cervical cancer can be attributable to HPV infection 
(CDC, 2017). Cervical cancer  is the second most common cancer among women in 
Nigeria (Ferlay et al., 2014). Cervical cancer morbidity and mortality is high in Nigeria, 
where an estimated 14,000 women are diagnosed annually with cervical cancer, and an 
estimated 26 women die every day of cervical cancer (Ogundipe, 2013). The reported age-
specific rate of cervical cancer in three states (Ibadan, Abuja, Calabar) were 36.0, 30.3, and 
21.0/100,000 among women 15 years of age and above; (Jedy-Agba, et al., 2012; Ekanem, 
et al., 2016). It is evident that cervical cancer is a disease affecting many women who may 
still be giving birth, raising children and supporting the family financially.  
HPV vaccines is projected to eliminate approximately 70% of cervical cancers and 
once-in-a-lifetime screening, performed by women in their 30s or 40s could reduce the risk 
of cervical cancer by 25 to 30% (WHO, 2014). Although the widespread availability and 
uptake of HPV vaccine and cervical cancer screening has significantly contributed to the 
declining incidence and mortality of HPV infection and cervical cancer in developed 
countries (Cuzick, et al., 2008), this is not the case in developing countries. Similar to the 
situation in many developing countries, the rates of HPV vaccination and cervical cancer 
screening in Nigeria are not known but presumed to be extremely low (Ndikom & Oboh, 
2017; Ogochukwu et al., 2017). Reports from recent investigations indicate fewer than 
14% of adolescent girls had received HPV vaccine (Ndikom & Oboh, 2017; Ogochukwu 
et al., 2017) and less than 10% of women have been cervical cancer screening (Idowu, 
Olowookere, Fagbemi, & Ogunlaja, 2016; Wright et al., 2014). Of particular note, Awodele 
and colleagues (2011) also reported poor uptake of cervical screening among nurses, with 
60% of the sample of 200 nurses reporting never having been screened for cervical cancer.  
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Amplifying this low uptake of cervical cancer screening in Nigeria are a wider 
range of personal, social, political and institutional factors. Commonly reported barriers 
include lack of awareness, poor knowledge of diseases and preventive measures, lack of 
spousal support, misperceptions, stigma and modesty, cultural beliefs and practices, cost 
of screening, access to and use of health facilities (Adetule, 2016; Lim & Ojo, 2017; 
Ndikom & Ofi, 2012; Ezeonwu, 2014; Modibbo et al., 2016). Furthermore, a woman’s risk 
of contracting HPV infection and subsequently developing cervical cancer depends not 
only on her own sexual behaviors and practices, but also on those of her male partner(s). 
The importance of involving men in reproductive health programs has gained increasing 
appreciation since the mid-1990s, given the recognition of the impact of sociocultural 
factors on women’s reproductive health. Men play significant roles in reproductive health 
through their sexual behaviors, emotional support, family decisions and control of family 
resources.  
Health education is an effective method of increasing awareness, knowledge, and 
utilization of HPV vaccination and cervical cancer screening services (Chigbu, Onyebuchi, 
Onyeka, Odugu, & Dim, 2017; Gana, Oche, Ango, Raji, & Okafoagu, 2016; Mbachu, Dim, 
& Ezeoke, 2017). Lack of awareness and knowledge and persistent misconceptions about 
HPV infection and cervical cancer may contribute to lower levels of perceived 
susceptibility and reduced uptake of the preventive measures (Becker, 1974). Interventions 
such as community outreach activities, educational fairs, individual mailings, telephone 
calls and health care provider reports have been designed to improve HPV vaccination and 
cervical cancer screening in different populations and at various levels (Falk, 2018; 
Okasako-Schmucker, et al., 2018; Kester, et al., 2014; Krawczyk, et al., 2012). Some 
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studies have evaluated community-directed cervical cancer screening interventions in 
Nigeria (Abiodun et al., 2014; Odunyemi, Ndikom, & Oluwatosin, 2018). A community 
health education nurse-directed 2-day workshop on cervical cancer and HPV vaccination 
reported very significant increases (mean score 9.6 ± 7.2 to 21.5 ± 6.2, p<.05) in 
knowledge, and more than 93% of mothers who participated were ready to accept HPV 
vaccination for their adolescent daughters (Odunyemi, Ndikom, & Oluwatosin, 2018). 
Another community-based intervention involving adult women in rural communities 
utilized multiple mediums including structured health education, didactic lectures, a movie 
and a handbill (pamphlet) to increase awareness of cervical cancer and cervical cancer 
screening by 83.1% (Abiodun et al., 2014).  
The assessment of the effectiveness of different educational strategies is pertinent 
as many health interventions deemed cost-effective are not affordable in developing 
countries because of resource limitations (Bilinski, et al., 2017). Adopting low-cost 
interventions that maximize health returns is essential in low resource settings.  Increasing 
universal coverage for interventions with high potential population health benefits is 
imperative in public health planning and implementation, especially for low resource 
settings, and residents in hard to reach areas. Prior research has shown that increasing 
awareness and knowledge of HPV, HPV vaccination, and cervical cancer, and cervical 
cancer screening has been effective in increasing both behavioral intention and behavior. 
Our aim was to implement an educational intervention, using two strategies, one that could 
be efficiently delivered to groups in natural settings such as churches, and one that could 
be delivered to individuals who may not be accessible in group settings. Based on the 
assumption that some members of the target population would be more accessible and/or 
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amenable to a group interventions and others to an individual intervention, two different 
intervention strategies that delivered the same content were employed to maximize 
population reach. To our knowledge, to date no study has evaluated the efficacy of two, 
low cost interventions for improving HPV vaccination and cervical cancer screening in 
Nigeria. Therefore, the aim of this research was to evaluate the preliminary efficacy of two 
different community-based health education intervention strategies, aimed at improving 
awareness and knowledge of: (1) HPV, HPV vaccination, cervical cancer, and cervical 
cancer screening, and (2) intention to take and or encourage HPV vaccination and cervical 
cancer screening among urban adults in Nigeria.  
The research site was Anambra, the eighth most populated state in Nigeria. 
Anambra residents have high literacy rates. The state is a highly-urbanized state with 62% 
of its population living in urban areas. It is located in the southeastern Nigeria, within an 
area of 1,870 mi², and a has a total of 5,366,900 (2013 estimate) inhabitants (National 
Population Commission of Nigeria, 2015). The educational interventions and data 
collection occurred from December 2017 to January 2018. 
Method 
This study employed pre-test and post-test design to evaluate the effectiveness of a 
community-based health education intervention, a face-to-face presentation delivered in 
group settings and printed pamphlet delivered to individuals. Both intervention strategies 
involved men and women.  
Participants. The study participants were men and women who met the inclusion 
criteria and volunteered to participate. The inclusion criteria were adults between the age 
of 18 and 65 years who were able to read and write in English. Participants who received 
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the face-to-face presentation (Presentation Group), and participants who received a printed 
pamphlet (Pamphlet Group) were allocated to groups using convenience sampling based 
upon setting, access, and individual preference. Participants recruited in large groups (e.g. 
churches, organizations) received face-to-face group-based education while participants 
recruited in single groups (e.g., large extended families) or alone received printed 
pamphlet-based education. Participation was voluntary and participants in both groups 
were given option to choose or reject either of the interventions. Only participants who 
completed the pre- and post-intervention surveys were included in the final analysis. A 
sample size of 200 participants were estimated. To account for possible attrition, 281 
participants were recruited; 168 participants were recruited for the Presentation Group and 
113 participants were recruited for the Pamphlet Group.  
To recruit participants, individual contacts were made with priests, lay leaders, and 
head of organizations, informing them of the study. Churches have been used effectively 
in health promotion interventions in communities in Nigeria, where faith has a substantial 
role with 87% of people reporting religious service attendance at least once a week 
(Ezeanolue, et al., 2015; Ucheaga, & Hartwig, 2010; Abanilla, et al., 2010). At other sites 
(e.g., hospitals, educational institution), the primary investigator approached individuals, 
and after verifying they met the inclusion criteria, extended an invitation to participate. A 
detailed explanation of the objectives, eligibility criteria, confidentiality, and the voluntary 
nature of study participation was done. All participants completed the paper-based, self-
administered pre- and post-surveys. Verbal informed consent was obtained, given that it is 
more culturally acceptable and appropriate than written consent in Nigeria. Human subject 
protection approval was received from the University of South Carolina Institutional 
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Review Board for which the primary investigator was affiliated.  All data were collected 
in a span of four weeks from December 2017 to January 2018. 
Intervention. The face-to-face presentation and printed materials were developed 
from available educational resources on the Center for Disease Control and Prevention 
(CDC) and the Foundation for Women’s Cancer websites (CDC, 2017; Foundation for 
Women’s Cancer, 2017). The educational content and presentation materials were adopted 
and modified by the primary investigator, a native Nigerian, to be culturally- and 
environmentally relevant to the target population. Both modalities had the same content 
which included: information on the HPV, HPV vaccine, cervical cancer and cervical cancer 
screening, statistical facts on incidence and prevalence of HPV and cervical cancer in 
Nigeria as well as the rate of HPV vaccination and cervical cancer screening, and common 
misconceptions about HPV, HPV vaccination, cervical cancer and cervical cancer 
screening.  
The intervention design included three phases. The pre-intervention phase was the 
administration of baseline information using the questionnaire. The intervention phase 
involved the administration of the health education intervention, in the form of either a 
face-to-face health presentation or a printed pamphlet. The total time (including pretest, 
intervention and posttest) for participants who received face to face presentations ranged 
between 40 and 60 minutes, whereas study participation time for those who received the 
pamphlet ranged from 20 to 80 minutes. Among both groups, the post-intervention phase 
involved re-administration of the questionnaire immediately following the educational 
intervention.  
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Survey Instrument. A questionnaire previously developed and used to assess 
awareness, knowledge, attitude and practice of HPV and cervical cancer preventive 
measures among 352 men in Nigeria was adopted and modified. Survey questions were 
based on and/or adapted from other existing surveys, including the Cervical Cancer Free 
Coalition National Surveys; Health Information National Trends Survey and previous 
studies on HPV and cervical cancer among men in sub-Saharan Africa (Maree, Wright, & 
Makua, 2011; Rosser, Zakaras, Hamisi, & Huchko, 2014; Rwamugira, Maree, & Mafutha, 
2017; Williams, & Amoateng, 2012). There were two versions of the English-language 
survey, one for men and the other for women. The men’s survey contained 44 questions 
and the women’s survey consisted of 47 questions. The three additional questions for 
women related to decision making. Each version addressed awareness, knowledge, 
attitude, intention and stigma. Question format included 4 open-ended questions and 40 
and 43 multiple-choice questions for men and women respectively. 
Data Analysis Strategies. Data were manually entered into an excel spreadsheet, 
crosschecked for correctness, and subsequently analyzed using Statistical Analysis System 
(SAS) software version 9.4. Data analysis consisted of descriptive statistics (mean, 
frequency and percentage) for socio-demographic variables. Differences between the 
demographic characteristics of the two groups were evaluated using t-test and Chi square 
statistics.  In regard to knowledge of HPV and cervical cancer, a composite score was 
computed for each respondent by assigning a score of 1 to each correct answer and 0 to 
each wrong answer. Their level of knowledge was scored and categorized as follows: 0-4 
is low, 5-9 is fair, 10-13 is high. Descriptive statistics were used to describe group 
frequencies pre-and post-test for each intervention group and changes in pre-post 
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knowledge changes were assessed independently for each group using ANOVA. The 
statistical significance was set at p < 0.05.  
Results 
  Of the 266 participants who completed both the pre-intervention and post-
intervention questionnaire, 163 were in the Presentation Group and 103 were in the 
Pamphlet Group. Socio-demographic characteristics of the participants are shown in Table 
3.1. Significant differences were found between the sociodemographic characteristics of 
the groups existed in age, sex, educational level and monthly income (p <0.05).  The mean 
age of the Presentation Group and Pamphlet Group was 35.6 ± 9.64 years and 38.8 ± 10.8 
years respectively. More than half of the participants were women (54.0% Presentation 
Group and 61.2% Pamphlet Group) and married (59.5% Presentation Group and 71.6% 
Pamphlet Group). There were no significant differences in marital status (p=0.2494) 
between the two groups. Overall, participants were well-educated, but fewer Presentation 
Group participants (71.6%) reported having college education than Pamphlet Group 
participants (84.3%). Despite high educational levels, 55.8% of Presentation Group 
participants and 36.0% Pamphlet Group participants reported less than 50,000 Nigerian 
naira monthly income (equivalent to $139 in the United States). The analysis of the 
demographic characteristics showed that the two groups were different, therefore their 
knowledge and intention to take HPV vaccine and Cervical Cancer screening were 
analyzed separately. 
Data on HPV and HPV vaccine knowledge and are presented in Table 3.2. The 
groups will be analyzed separately because the participants differ in many of their baseline 
characteristics. Only participants who took the pre and posttest were included in the 
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analysis. There are differences in the number of responses per item because participants 
who had never heard of HPV were told to skip the other HPV knowledge questions.  
Table 3.1: Summary of Participant Demographics  
Characteristic Presentation 
Group n (%) 
Pamphlet 
Group n (%) 
t-test 
Age, years (mean+SD) 35.6+9.64) 38.8+10.8 0.0168 
Age group (years)    
18 -24 5 (3.14) 3 (2.94) 0.0370 
25 - 34     71 (44.7) 43 (42.2)  
35 - 44       57 (35.9) 23 (22.6)  
45 - 54       18 (11.3) 23 (22.6)  
55 and above  8 (5.03) 10 (9.80)  
Sex     
Men  75 (46.0) 40 (38.8)  0.0427 
Women  88 (54.0) 63 (61.2)  
Marital status     
Single 66 (40.5) 29 (28.4) 0.2494 
Married 97 (59.5) 73 (71.6)  
Educational level    
No formal education 0 (0.00) 0 (0.00) 0.0614 
Primary education  3 (1.85) 2 (1.94)  
Secondary education  43 (26.5) 14 (13.7)  
Tertiary education  116 (71.6) 86 (84.3)  
Monthly income    
Less than #50, 000 86 (55.8) 36 (36.0) 0.0054 
#50-100,000 34 (22.1) 32 (32.0)  
Above #100,000 34 (22.1) 32 (32.0)  
 
For the Presentation Group, at pre-intervention, 17.8% of respondents had heard of 
HPV infection, whereas on the post-test, 91.4% reported knowledge of HPV infection, and 
23.3% knew that HPV is a sexually transmitted virus, with a statistically significant 
difference (p < 0.05). Also, less than one-fourth of participants reported knowing that men 
and women can contract HPV infection prior to the intervention, whereas at post-
intervention, more than 82% reported knowledge. At baseline, level of awareness of HPV 
 50 
vaccine was 11.8%, which rose to 88.8% at post intervention, with a statistically significant 
difference (p<0.05).  
About 27.2% of Pamphlet Group respondents had heard of HPV infection at 
preintervention, whereas on the post-test, 98.1% reported knowledge of HPV infection 
(p < 0.05), as shown in Table 3.2. At baseline, 35.0% knew that HPV is a sexually 
transmitted virus, while 98.1% participants reporting awareness of HPV at postintervention 
(p < 0.05). Prior to the intervention, 25% of the participants reported knowing that men 
and women can contract HPV infection, whereas at post-intervention, more than 82% 
reported knowledge. The level of awareness of HPV vaccine was 20.4% at baseline and 
increased 85.4% at postintervention (p<0.05).  
Table 3.3 presents findings related to participants’ knowledge of cervical cancer 
and cervical cancer screening. Similar to HBV knowledge, the two groups were different 
at baseline and, therefore, the groups were analyzed separately. The proportion of 
Presentation Group participants at pre-intervention, who had heard of cervical cancer was 
64.2% and rose to 93.8% at post-intervention (p <0.05). About 36.8% reported knowing 
that smoking and multiple sexual partners increases the risk of getting cervical cancer at 
baseline, which increased to more than 65% knew post intervention (p < 0.05). Only 25.8% 
of Presentation Group participants knew cervical cancer is associated with HPV infection 
at baseline, and at post-intervention, more than 85% of participants were aware that 
cervical cancer is associated with HPV infection with a significant difference of (p < 0.05). 
Additionally, at pre-intervention, among the Presentation Group participants only 13% and 
14.9%, respectively had heard of about the pap smear test or VIA, which were statistically 
significant (p <0.05) at post-intervention.   
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Table 3.2. Participant Knowledge of HPV and HPV Vaccine Pre- and Post-Intervention  
Variables  Presentation Group n (%) Pamphlet Group n (%) 
 Pre  Post  p Pre  Post  P 
Have you ever heard 
of HPV?              No 
Yes 
Not sure 
 
112(68.7) 
29(17.8) 
22(13.5) 
 
8(4.91) 
149(91.4) 
6(3.98) 
 
 
<.0001 
 
66(64.1) 
28(27.2) 
9 (8.74) 
 
1(0.97) 
101(98.1) 
1(0.97) 
 
 
<.0001 
How do you think 
one can get HPV?  
Physical contact  
Dirty toilets  
Poor personal 
hygiene 
Sexual intercourse 
 
 
 
6(3.68) 
12(7.36) 
16(9.60) 
38(23.3) 
 
 
 
17(10.6) 
13(7.98) 
18(11.0) 
151(92.6) 
 
 
 
<.0001 
0.4505 
0.4670 
<.0001 
 
 
 
2(1.94) 
1(0.87) 
2(1.94) 
36(35.0) 
 
 
6(5.83) 
4(3.88) 
3(2.91) 
101(98.1) 
 
 
<.0001 
0.0034 
0.0678 
<.0001 
How do you know 
when someone has 
HPV?  
Itching  
Pain during 
urination 
Genital discharges 
Genital rash 
No symptoms 
 
 
 
 
18(11.0) 
10(9.71) 
15(9.20) 
16(9.82) 
10(6.13) 
 
 
 
 
151(92.6) 
25(15.3) 
37(22.7) 
13(7.98) 
103(63.1) 
 
 
 
 
<.0001 
0.0002 
<.0001 
0.4180 
<.0001 
 
 
 
 
10(9.71) 
4(3.88) 
14(13.6) 
12(11.7) 
13(12.6) 
 
 
 
 
101(98.1) 
10(9.71) 
50(48.5) 
19(18.5) 
33(32.0) 
 
 
 
 
<.0001 
0.0152 
<.0001 
0.0396 
<.0001 
Who can contract 
HPV?  
Male only 
Female only 
Male and female 
 
 
0(0) 
11(6.74) 
41(25.2) 
 
 
0(0) 
6(3.82) 
151(96.2) 
 
 
 
 
0.0016 
 
 
9(8.87) 
9(8.87) 
26(25.2) 
 
 
2(1.94) 
13(12.6) 
85(82.5) 
 
 
 
 
<.0001 
What factors 
increase the risk of 
getting HPV?  
Poor diet  
Smoking  
Poor personal 
hygiene Multiple 
sexual partners  
 
 
 
 
6(3.68) 
7(4.29) 
16(9.82) 
39(23.9) 
 
 
 
 
5(3.07) 
41(25.2) 
25(15.4) 
147(90.7) 
 
 
 
 
0.2124 
<.0001
0.0024 
<.0001 
 
 
 
 
0(0) 
11(10.7) 
3(2.91) 
33(32.0) 
 
 
 
 
2(1.94) 
48(18.1) 
5(4.85) 
92(89.3) 
 
 
 
 
<.0001
<.0001 
0.0612 
<.0001 
Have you heard 
about HPV vaccine?         
No                        
Yes  
Not sure 
 
 
133(82.6)
19(11.8) 
9(5.59) 
 
 
16(9.94) 
143(88.8) 
2(1.24) 
 
 
 
<.0001 
 
 
77(74.8) 
21(20.4) 
5(4.85) 
 
 
9(8.74) 
88(85.4) 
6(5.83) 
 
 
 
<.0001 
Who can take the 
vaccine?  
Boys and girls  
Young men and 
women  
 
 
14(8.59) 
23(14.4) 
 
 
96(58.9) 
103(63.2) 
 
 
<.0001 
 
 
15(14.6) 
22(21.4) 
 
 
64(62.1) 
66(64.1) 
 
 
<.0001 
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For participants in Pamphlet Group, the proportion of participants who had heard 
of cervical cancer was 71.8% at baseline and rose to 92.1% at post-intervention. At pre- 
51.3% of the participants reported knowing that smoking and multiple sexual partners 
increases the risk of getting cervical cancer (p < 0.05). however, at post-intervention, 
51.5% and 89.3% of the participants knew that cervical cancer is associated with and 
infection respectively (p < 0.05).  
Also, 67.0% of the participants knew cervical cancer is associated with HPV 
infection, and 92.2% became aware at postintervention (p < 0.05). Only 37.9% and 31.1% 
respectively had heard of the pap smear and HPV tests; which increased to almost 70% and 
were statistically significant (p <0.05). Both community-based educational methods 
significantly increased participants’ knowledge of cervical cancer and cervical cancer 
screening as shown in Table 3.3.  
Participants’ Level of Knowledge of HPV and Cervical Cancer. Table 3.4 
shows the respondents level of knowledge of HPV and cervical cancer. In the Presentation 
Group 85.3% had poor knowledge, 9.82% had moderate and 4.91% had high level of 
knowledge of HPV and HPV vaccine, with significant improvements made at post-
intervention.  
Participants in the Pamphlet Group also significantly improved their knowledge of 
HPV and HPV vaccine from pre-test to post-test. Those who had high knowledge of HPV 
and HPV vaccine increased from 5.88% to 46.6%. In addition, both groups significantly 
increased knowledge of cervical cancer and cervical cancer screening as shown below in 
Table 3.4.  
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Table 3.3 Knowledge of Cervical Cancer and Cervical Cancer screening Pre-intervention 
(Pre) and Post intervention (Post). 
Variables  Presentation Group n (%) Pamphlet Group n(%) 
 Pre Post p Pre Post p 
Have you ever heard 
of cervical cancer? 
No  
Yes 
Not sure  
 
 
34(21.0) 
104(64.2) 
24(14.8) 
 
 
3(1.86) 
151(93.8) 
6(5.94) 
 
 
 
<.0001 
 
 
25(24.2) 
74(71.8) 
4(3.88) 
 
 
2(1.98) 
93(92.1) 
6(5.94) 
 
 
 
0.0001 
Which of the 
following do you 
think increases the 
risk of getting cervical 
cancer?          Smoking 
Multiple sexual 
partners 
 
 
 
 
40(24.5) 
62(38.0) 
 
 
 
 
60(36.8) 
136(83.4) 
 
 
 
 
0.0020 
<.0001 
 
 
 
 
26(25.2) 
71(68.9) 
 
 
 
 
53(51.5) 
92(89.3) 
 
 
 
 
<.0001 
Do you think cervical 
cancer is associated 
with an infection?  No 
Yes 
 
 
51(34.7) 
96(65.3) 
 
 
9(5.73) 
148(94.3) 
 
 
 
<.0001 
 
 
32(33.0) 
65(67.0) 
 
 
8(7.77) 
95(92.2) 
 
 
 
<.0001 
If yes; what type of 
infection is cervical 
cancer associated 
with?  
HPV infection  
 
 
 
42(25.8) 
 
 
 
140(85.9) 
 
 
 
<.0001 
 
 
 
57(57.0) 
 
 
 
92(89.3) 
 
 
 
<.0001 
Cervical cancer be 
prevented?           No 
Yes     
 
21(14.2) 
127(85.8) 
 
3(1.92) 
153(98.1) 
 
 
0.0201 
 
11(10.7) 
92(89.3) 
 
6(5.83) 
97(94.2) 
 
 
0.0082 
Early detection of 
cervical cancer is 
helpful?                 No 
Yes 
 
 
14(9.21) 
138(90.8) 
 
 
6(3.82) 
151(96.2) 
 
 
0.0075 
 
 
6(5.88) 
96(94.1) 
 
 
1(1.03) 
96(99.0) 
 
 
0.1967 
Have you heard about 
Pap smear test or 
Visual Inspection 
with Acetic Acid 
(VIA)?                  No  
Yes  
Not sure 
 
 
 
 
113(69.8) 
21(13.0) 
28(17.3) 
 
 
 
 
11(6.75) 
138(84.7) 
14(8.59) 
 
 
 
 
 
<.0001 
 
 
 
 
55(53.4) 
39(37.9) 
9(8.74) 
 
 
 
 
21(20.4) 
72(69.9) 
10(9.71) 
 
 
 
 
 
<.0001 
Have you heard about 
HPV test?              No                     
Yes 
Not sure 
 
119(73.9) 
24(14.9) 
18(11.2) 
 
12(7.50) 
136(85.0) 
12(7.50) 
 
 
<.0001 
 
55(53.4) 
32(31.1) 
16(15.5) 
 
9(8.74) 
90(87.4) 
4(3.88) 
 
 
<.0001 
Who can take Pap 
smear test or VIA or 
HPV test?        Women 
 
 
40(24.5) 
 
 
137(84.1) 
 
 
<.0001 
 
 
57(55.9) 
 
 
92(89.3) 
 
 
<.0001 
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Table 3.4: Participants Level of Knowledge of HPV, HPV Vaccine, Cervical Cancer and 
Cervical Cancer screening Pre and Post intervention. 
Variables  Presentation Group n(%) Pamphlet Group n(%) 
 Pre Post p Pre Post p 
Level of Knowledge 
of HPV and HPV 
Vaccine. 
Poor 
Moderate 
High  
 
 
 
139(85.3) 
16(9.82) 
3(4.91) 
 
 
 
13(7.98) 
61(37.4) 
89(54.6) 
 
 
 
 
<.0001 
 
 
 
82(80.4) 
14(13.7) 
6(5.88) 
 
 
 
20(19.4) 
35(34.0) 
48(46.6) 
 
 
 
 
<.0001 
Level of Knowledge 
of Cervical Cancer 
and Cervical Cancer 
screening?      
Poor 
Moderate 
High  
 
 
 
 
64(39.3) 
63(38.6) 
36(22.1) 
 
 
 
 
12(7.36) 
29(17.8) 
122(74.9) 
 
 
 
 
 
<.0001 
 
 
 
 
21(20.4) 
23(22.3) 
59(57.3) 
 
 
 
 
3(2.91) 
16(15.5) 
84(81.6) 
 
 
 
 
 
0.0002 
 
Reported Uptake of HPV Vaccine and Cervical Cancer Screening at Baseline. 
Less than 8% of respondents in both groups had received either the HPV vaccine 
themselves or knew of a family member had taken HPV vaccine. Data regarding baseline 
uptake of cervical cancer prevention and screening is presented in Table 3.5. As shown, 
the number of men and women who had received the HBV vaccination were similar and 
there was little difference between groups (p > 0.05).  Additionally, very few people in 
either group, 5.52% in the Presentation Group and 11.6% in the Pamphlet Group, received 
or had a family member who had received a pap smear or VIA test (p > 0.05).  
Intention to take and or encourage HPV Vaccine. Table 3.6 presents the study 
participants’ intent to receive and or encourage HPV vaccine before and after the 
intervention. Participants were asked questions about their willingness to take, encourage 
and pay for a family member or their uptake of HPV vaccine. Less than 19% of respondents 
in the Presentation group planned to receive HPV vaccine, and only 26.7% were willing to 
encourage a family member or friend to receive the HPV vaccine at baseline. At post-
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intervention, 69.1% planned to receive HPV vaccine, and 85.3% were willingness to 
encourage a family member or friend to receive the HPV vaccine (p < 0.05 for both pre- 
versus post-test). In addition, participants indicating an intent to pay to receive or for a 
family member to get HPV vaccine pre-intervention was 31.3% among Presentation Group 
participants and increased to 63.4% with a significant difference (p <0.05).   
About 18.5% and 45.6% of respondents in the Pamphlet Groups planned to receive 
HPV vaccine and were willingness to encourage a family member or friend to receive the 
HPV vaccine, respectively, at baseline. Intentions towards HPV vaccination significantly 
increased to more than 53% at post-intervention, which was significantly different from 
baseline in (p < 0.05). Similarly, participants intent to pay to receive or for a family member 
to get HPV vaccine was 40.8% at pre-intervention and rose to more than 73% at post-
intervention (p <0.05). As shown in Table 3.6, at post-intervention, we observed an 
increase in participants’ intent to receive, encourage and pay for HPV vaccine in both 
groups. 
Table 3.5: HPV Vaccine and Cervical Cancer Screening Rate 
Variables Presentation Group 
n(%) 
Pamphlet Group 
n(%) 
Have you or anyone in your family 
had HPV vaccine? If Yes, who?      
Me  
Wife 
Daughter 
Son 
Others 
Nobody 
 
 
4 (2.45) 
2 (1.23) 
0 (0) 
0 (0) 
2 (1.23) 
147 (91.8) 
 
 
2 (1.94) 
0 (0) 
2 (1.94) 
0 (0) 
4 (3.88) 
95 (92.23) 
Have you or anyone in your 
family done a pap smear or VIA 
test? If Yes, who?                                             
Wife 
Daughter 
Others 
Nobody 
 
 
6 (3.68) 
0 (0.00) 
3 (1.84) 
149 (91.4) 
 
 
5 (4.85) 
3 (2.91) 
4 (3.88) 
82 (79.6) 
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Table 3.6. Intention to encourage and or take HPV Vaccine. 
Variables  Presentation Group n(%) Pamphlet Group n(%) 
 Pre Post p Pre Post P 
Do you plan to take 
HPV vaccine?                                 
No  
Yes  
Maybe  
 
51(31.3) 
30(18.4) 
82(50.3) 
 
 
20(12.5) 
112(69.1) 
30(18.5) 
 
 
 
<.0001 
 
 
47(45.6) 
19(18.5) 
37(35.9) 
 
 
23(22.3) 
55(53.4) 
25(24.3) 
 
 
 
<.0001 
Will you encourage 
your family member 
or friends to take 
HPV vaccine?                                 
No  
Yes 
Maybe 
 
 
 
15(9.32) 
43(26.7) 
103(64.0) 
 
 
 
 
2(1.23) 
139(85.3) 
22(13.5) 
 
 
 
 
 
<.0001 
 
 
 
 
15(14.6) 
47(45.6) 
41(39.8) 
 
 
 
 
12(11.7) 
7(73.8) 
15(14.6) 
 
 
 
 
 
<.0001 
Who will you 
encourage to take 
HPV vaccine?      
Wife 
Daughter 
Son 
Others 
Nobody 
 
 
 
11(14.7) 
44(27.0) 
36(22.2) 
38(23.3) 
80(49.1) 
 
 
 
45(43.7) 
106(65.0) 
103(63.2) 
72(44.2) 
20(12.3) 
 
 
 
 
 
<.0001 
 
 
 
17(10.4) 
49(30.1) 
26(25.2) 
27(26.2) 
22(21.4) 
 
 
 
18(17.5) 
83(80.6) 
74(71.8) 
41(39.8) 
8(7.77) 
 
 
 
 
0.8185 
<.0001 
<.0001 
0.0133 
Will you pay to 
receive or for a family 
member to get HPV 
vaccine, If the vaccine 
cost too much?                                            
 No 
Yes  
Maybe  
 
 
 
 
27(16.6) 
51(31.3) 
85(52.1) 
 
 
 
 
11(6.79) 
109(67.3) 
42(25.9) 
 
 
 
 
 
 
<.0001 
 
 
 
 
 
21(20.4) 
42(40.8) 
40(38.8) 
 
 
 
 
 
7(6.93) 
64(63.4) 
30(29.7) 
 
 
 
 
 
 
0.0007 
 
Intention to take and or encourage Pap smear or VIA. Similar to other survey 
items significant increases were noted in both groups’ intention to receive and willingness 
to encourage a family member to receive a screening post-intervention (Table 3.7). Among 
the women surveyed in the Presentation Group, 37.5% were planning to receive screening, 
and the proportion of respondents willing to encourage family member to receive screening 
at baseline was 44.8%. These intentions increased significantly within the Presentation 
Group at following the educational intervention (p < 0.05). The proportion of participants 
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willing to pay to receive or to pay for a family member to receive a pap smear was 34.0% 
at pre-intervention phase, with no significant increase at post-intervention (p > 0.05).   
For pamphlet group, 33.3% of the women surveyed were planning to receive 
screening, and 51.5% were willing to encourage family member to receive screening at 
baseline. However, at post intervention, more than 61% of both participants were planning 
to receive screening and were willing to encourage family member to receive screening (p 
< 0.05 for both intentions pre- versus post-test). The proportion of participants in the 
pamphlet group willing to pay to receive or to pay for a family member to receive a pap 
smear was 46.6% at baseline slightly increased (59.2%) at post-intervention, but the 
changes was not statistically significant. 
Table 3.7. Intention to Encourage and or Take Cervical Cancer Screening. 
Variables  Presentation Group n(%) Pamphlet Group n (%) 
 Pre Post p Pre Post P 
Do you plan to go for 
cervical cancer 
screening (Women 
only)?    
No 
Yes 
Not sure 
 
 
 
 
23(26.1) 
33(37.5) 
32(36.4) 
 
 
 
 
4(4.55) 
74(84.1) 
10(11.4) 
 
 
 
 
 
<.0001 
 
 
 
 
34(54.0) 
21(33.3) 
8(12.7) 
 
 
 
 
15(23.8) 
39(61.9) 
9(14.3) 
 
 
 
 
 
0.0004 
Will you encourage 
any of your family 
member to receive pap 
smear?    
No 
Yes 
Not sure 
 
 
 
15(9.20) 
73(44.8) 
75(46.0) 
 
 
 
3(1.84) 
138(84.7) 
22(13.5) 
 
 
 
 
<.0001 
 
 
 
11(10.7) 
53(51.5) 
39(37.9) 
 
 
 
11(10.7) 
81(78.6) 
11(10.7) 
 
 
 
 
<.0001 
Will you pay to 
receive or for a family 
member to receive a 
pap smear; if the test 
cost too much?                    
No 
Yes 
Not sure  
 
 
 
 
15(9.26) 
55(34.0) 
92(56.8) 
 
 
 
 
 
12(7.36) 
119(73.0) 
32(19.6) 
 
 
 
 
 
 
<.0001 
 
 
 
 
 
22(21.4) 
48(46.6) 
33(32.0) 
 
 
 
 
 
19(18.5) 
61(59.2) 
23(22.3) 
 
 
 
 
 
 
0.0633 
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Logistic regression of factors associated with participants’ level of knowledge 
of HPV and cervical cancer. The adjusted model for level of knowledge of HPV and HPV 
vaccine is presented in Table 3.8. The adjusted model included age group, marital status, 
education and income. For the Presentation group, the odds of increased knowledge of 
HPV and HPV vaccine at post intervention for participants between age 18-24 years is 18.1 
times higher than the odds of increased knowledge of HPV and HPV vaccine for 
participants who are 55 years and older, statistical significant difference. Similarly, the 
odds of high knowledge of HPV and HPV vaccine for men is 1.17 times higher than the 
odds of high knowledge of HPV and HPV vaccine for women with no statistical significant 
difference. Also, no significant difference was observed based on the participants’ marital 
status, educational level and monthly income. 
For the Participants in the Pamphlet group, the odds of increased knowledge of 
HPV and HPV vaccine at post intervention for participants between age 45-54 years is 1.45 
times higher than the odds of increased knowledge of HPV and HPV vaccine for 
participants who are 55 years and older, with no statistical significant difference. The odds 
of increased knowledge of HPV and HPV vaccine were not significantly difference among 
participants in the Pamphlet group based on the sex, marital status, educational level and 
monthly. 
Results of the regression analyses (Table 3.9) indicated the odds of high 
knowledge of cervical cancer and cervical cancer screening among participants in various 
groups. For the Presentation group, the odds of high knowledge of cervical cancer and 
cervical cancer screening for participants aged 18-24 is 18.1 times and 5.7 times for 
participants aged 45 to 55 than the odds of high knowledge for those who are 55 years and 
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above with significant difference. However, the odds of high knowledge of cervical cancer 
and cervical cancer screening were not significantly different among the participants based 
on the sex, marital status, educational level and monthly income. Additionally, for the 
pamphlet group, the odds of high knowledge of cervical cancer and cervical cancer 
screening were not significant among participants based on the age group, sex, marital 
status, educational level and monthly income.  
Table 3.8: Regression Analysis of Factors Associated with High Knowledge of HPV and 
HPV Vaccine. 
 Presentation Group Pamphlet Group  
 Odds 
ratio 
95% CI for OR Odds 
ratio 
95% CI for OR 
Lower Upper Lower Upper  
Age Group 
18 - 24      
25 - 34  
      35 - 44  
      45 - 54  
      55+ (referent) 
 
Sex 
Men  
Women (referent)  
  
Marital Status 
      Single 
Married (referent)  
 
Education Level 
No formal education  
Primary education  
Secondary education 
Tertiary education 
(referent) 
Monthly income 
(Nigerian Naira) 
Less ₦50,000 (referent)  
 ₦50-100,000 
Above ₦100,000 
 
18.0889 
3.7556 
2.8739 
5.7819 
 
 
 
1.1667 
 
 
 
0.7746 
 
 
 
 
0.2146 
0.7769 
 
 
 
 
 
0.8277 
2.1735 
 
2.4854 
0.2555 
0.8300 
1.4558 
 
 
 
0.6203 
 
 
 
0.3936 
 
 
 
0.06190 
0.4143 
 
 
 
 
 
0.3634 
0.9340 
 
131.65 
1.6513 
9.9512 
22.9636 
 
 
 
2.1944 
 
 
 
1.5248 
 
 
 
0.4488 
1.4568 
 
 
 
 
 
1.8853 
5.0581 
 
1.4530 
3.8089 
3.0244 
2.2758 
 
 
 
1.0025 
 
 
 
0.5160 
 
 
 
0.0298 
2.3555 
1.7533 
 
 
 
 
 
0.3768 
2.1404 
 
0.2893 
0.8097 
0.6380 
0.5400 
 
 
 
0.5032 
 
 
 
0.1987 
 
 
 
0.1696 
0.6679 
0.7635 
 
 
 
 
 
0.1594 
0.9397 
 
7.2981 
17.9179 
14.3365 
9.5903 
 
 
 
1.9974 
 
 
 
1.3402 
 
 
 
0.9854 
8.3076 
4.0261 
 
 
 
 
 
0.8906 
4.8752 
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Table 3.9: Regression Analysis of Factors associated with High Knowledge of Cervical 
Cancer and Cervical Cancer Screening. 
 Presentation Group  Pamphlet Group 
 Odds 
Ratio 
95% CI for OR Odds 
ratio  
95% CI for OR 
Lower  Upper  Lower  Upper  
Age group 
18 - 24      
25 - 34  
      35 - 44  
      45 - 54  
      55+ (referent)  
Sex 
Men  
Women (referent)  
 
Marital status 
Single 
Married (referent) 
 
Education Level 
No formal education  
Primary education  
Secondary education 
Tertiary education 
(referent) 
 
Monthly income 
(Nigerian Naira) 
    < ₦50,000 (referent)   
 ₦50-100,000 
Above ₦100,00  
 
1.2511 
1.6448 
2.4658 
5.2721 
 
 
0.3842 
 
 
 
1.0247 
 
 
 
 
0.8375 
0.3418 
 
 
 
 
 
 
1.2653 
2.3073 
 
0.2668 
0.4682 
0.8182 
1.4257 
 
 
0.2118 
 
 
 
0.5073 
 
 
 
 
0.3487 
0.1812 
 
 
 
 
 
 
0.6081 
0.9897 
 
5.8680 
5.7784 
7.4318 
19.4956 
 
 
0.6971 
 
 
 
2.0699 
 
 
 
 
2.0116 
0.6449 
 
 
 
 
 
 
2.6330 
5.3789 
 
0.4377 
4.1428 
1.6761 
1.7647 
 
 
0.5259 
 
 
 
0.3154 
 
 
 
0.2387 
0.01479 
0.6495 
 
 
 
 
 
0.9121 
1.4486 
 
0.1045 
1.2717 
0.4377 
0.5947 
 
 
0.2507 
 
 
 
0.1255 
 
 
 
0.06620 
0.005176 
0.3468 
 
 
 
 
 
0.3537 
0.5181 
 
1.8335 
13.4960 
6.4176 
5.2369 
 
 
1.1033 
 
 
 
0.7930 
 
 
 
0.8607 
0.04227 
1.2161 
 
 
 
 
 
 
2.3521 
4.0503 
 
Discussion  
Given that it is important to increase knowledge of HPV and cervical cancer and 
engage as many individuals as possible in healthy behavior, offering differing learning 
modalities is very vital to increase the reach of educational interventions in an effort to 
improve the overall health of a population. To our knowledge, this is the first study to 
assess the effectiveness of a community-based intervention that used two educational 
intervention strategies to improve awareness and knowledge of HPV, cervical cancer and 
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the preventive measures and their intention to engage in and encourage HPV vaccine and 
cervical cancer screening in Nigeria. Even though, other studies had utilized various 
interventions, presumed to be low cost, they delivered more than one low-cost intervention 
per participant, included only women, and/or did not recruit participants from various 
locations. The majority of the studies were clinic-based, not community-based. 
(Odunyemi, Ndikom, & Oluwatosin, 2018; Ndikom, Ofi, Omokhodion, & Adedokun, 
2017). One of the studies that utilized a community-based approach, focused on only rural 
women, and assessed only cervical cancer (Abiodun, Olu-Abiodun, Sotunsa, & Oluwole, 
2014). The recruitment of participants from various locations in this study, increased the 
opportunity to reach individuals who are not associated with groups, such as churches.  
Our findings indicate that targeted educational intervention strategies may 
contribute to increasing knowledge and intended practices related to HPV vaccination and 
cervical cancer screening. The findings are of particular significance considering the high 
incidence and prevalence of HPV infection and cervical cancer morbidity and mortality in 
Nigeria. Given that increased HPV vaccination coverage to a level of about 70% of the 
population can substantially reduce the prevalence of HPV infections, cervical 
abnormalities and invasive cervical cancer (WHO, 2009); increasing HPV immunization 
awareness, knowledge, and intention are critical. Furthermore, a once-in-a-lifetime 
screening of women in between 30 and 50 years of age could reduce the risk of cervical 
cancer by 25 to 30% (WHO, 2014).  
In this research, both educational modalities (face-to-face group presentation and 
educational pamphlets) were effective with in Nigerian adults’ HPV awareness, knowledge 
and behavioral intent. At baseline, most participants had very low knowledge levels related 
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to HPV infection, cervical cancer, and related preventive measures. Prior research in 
Nigeria has indicated low levels of knowledge of HPV and cervical cancer (Jamda, et al., 
2018; Abiodun et al., 2014). In a community-based cervical cancer education initiative 
among market women in an urban area of Lagos, Nigeria, Wright, Kuyinu, and Faduyile 
(2010) reported that at pre-intervention, over 75% of participants had no knowledge of 
cervical cancer pre-intervention. Similarly, Adamu and Colleagues (2012) reported that the 
vast majority of the female teachers in Birnin-Kebbi, North-Western Nigeria, who 
participated in their study had very low knowledge of cervical cancer at baseline.  
Findings from the present study indicated a marked improvement in the proportion 
of correct answers to specific questions about the HPV and cervical cancer risk factors, 
mode of transmission, symptoms, and methods of prevention and about HPV vaccine and 
cervical screening among the participants in both groups after the educational 
intervention. More than 82% of the participants in both group correctly answered most 
questions. It is important to note that both groups received the same information, but in 
different formats (i.e., group presentation or written information). The significant increase 
in level of HPV knowledge was similar to other studies carried out in Nigeria (Wright, 
Kuyinu, & Faduyile, 2010; Ndikom, Ofi, Omokhodion, & Adedokun, 2017) and other 
developing countries (Chang et al., 2013). For example, Adamu, Abiola, and Ibrahim 
(2012) noted an improvement of 124.3% in the mean knowledge of cancer of the cervix 
score among female teachers exposed to an educational intervention in North-Western 
Nigeria (Adamu, Abiola, & Ibrahim, 2012).  
Overall, the level of knowledge of participants in both groups improved. In the 
Presentation Group, the percentage with poor initial knowledge (85.3%) of HPV and HPV 
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Vaccine was reduced to 7.98% and among the Pamphlet Group, there was a similar 
reduction in poor initial knowledge from 80.4% to 19.4%. A statistically significant 
increase in those with very good knowledge were observed from a very low 4.91% to 
54.6% and 5.88% to 46.6% in the Presentation and Pamphlet Groups respectively. 
Likewise, for cervical cancer and cervical cancer screening, the proportion of participants 
with good knowledge rose from 22.1% to 74.9% in the Presentation Group from 57.3% to 
81.6% in the Pamphlet Group B, while those with poor knowledge reduced from 39.3% to 
7.36% and 20.4% to 2.91% in the respective groups. This finding is higher than those 
reported by Ndikom and colleagues that indicated at baseline 55% of nurses who 
participated in the educational intervention had poor knowledge, 30% had fair knowledge, 
and only 15% had high level of knowledge, whereas at post-intervention 26.8% had poor 
knowledge, 48.3% had fair knowledge and 33.3% had high knowledge (Ndikom, Ofi, 
Omokhodion, Bakare, & Adetayo, 2017). However, in their research on Nigerian market 
women, Gana and colleagues (2016) reported that initially less than 10% were aware of the 
pap smear but that 34% reported increased awareness following the intervention.  
The low levels of awareness and knowledge observed at baseline in this research 
may have contributed to reported low uptake of HPV vaccine and cervical cancer screening 
among family members. Less than 8% of participants reported having received the HPV 
vaccine and only 12% reported having a family member who had a pap smear. These 
findings are consistent with the research conducted by Mbamara and colleagues that found 
over 85% of the women attending gynecology clinics in a tertiary medical center in South-
eastern Nigeria had never received cervical screening, despite having attended the 
gynecology clinics (Mbamara et al., 2011). Various studies had recorded much lower rates 
 64 
of vaccine and screening in different parts of the country. In Abuja, Nigeria, only 1.4% of 
mothers reported having a daughter who had received HPV vaccination (Odunyemi, 
Ndikom, & Oluwatosin, 2018). Similarly, very low rates (i.e., less than 11%) of cervical 
screening service utilization were reported among female health workers in Sokoto (Oche, 
Kaoje, Gana, & Ango, 2013), and civil servants in Plateau (Hyacinth, Adekeye, Ibeh, & 
Osoba, 2012).  
It is important to note that the vast majority of research aimed at assessing the 
uptake of HPV vaccination in Nigeria focuses only on girls, despite the fact that the HPV 
vaccine is recommended for both boys and girls. Our findings indicated less than 2% of 
the respondents reported having a daughter who had been vaccinated and none reported 
having a son who had received the vaccine. Odunyemi and colleagues (2018) reported that 
85.5% of the mothers they surveyed reported lack of information was a deterrent to having 
their daughters take the vaccine. The fact that HPV vaccine frequently is referred to as a 
“cervical cancer vaccine” may contribute to limited awareness that the vaccine is also 
appropriate for boys. Of note, Jones and colleagues (2016) reported that half of the college 
male students were unaware that the HPV vaccine could be given to males. Also, of note, 
most published articles in Nigeria tend to address HPV as a virus that causes cervical 
cancer, rather than an infection in and of its own right, thus making it seem is only a concern 
for women (Odunyemi, Ndikom, & Oluwatosin, 2018; Wright, Kuyinu, & Faduyile, 2010; 
Wright, Aiyedehin, Akinyinka, & Ilozumba, 2014). 
We also found support for our second objective, which was intention to take and or 
encourage HPV vaccine and cervical cancer screening. These findings indicated significant 
improvement in reported intent to take and/or encourage HPV vaccination and cervical 
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cancer screening among individuals in both groups. Whereas less than 46% of the 
respondents were willing to take and or encourage their family member to receive HPV 
vaccine and cervical cancer screening at baseline, approximately 73% of participants were 
willing to do so post-intervention. These rates are lower than those reported in a study 
among antenatal women in Ibadan Nigeria (Ndikom, Ofi, Omokhodion, & Adedokun, 
2017), where at baseline, not less than 70% of their participants reported a willingness to 
utilize cervical cancer screening services, more than 85% were willing to utilize the 
services post-intervention. Similarly, Odunyemi and colleagues (2018) reported that 73.9% 
of the mothers who participated in a 2-day workshop were ready to accept HPV vaccination 
for their adolescent daughters at baseline, whereas 93.8% were willing to do so 3 months 
post-intervention. Among urban residential women in southeast Nigeria, the majority of 
participants were reported to be willing to be screened both before and after the intervention 
(Mbachu, Dim, & Ezeoke, 2017). The high rate of acceptance of and willingness to 
participate in HPV vaccination observed in that study may be attributed to the predominant 
acceptance of routine childhood vaccinations among Nigerian men and women.  
Exploratory subgroup analyses suggested that younger participants aged (18-24) 
were more likely to know about HPV and HPV vaccine. This may be attributed to their 
younger age and possible prior personal exposure to HPV vaccination. Of note, there were 
no differences associated with marital status, levels of education, or monthly income. In 
contrast, Mbachu and colleagues (2017) reported no significant associations between 
difference in screening practices and respondents’ age but did find statistical significant 
difference with marital status and levels of education. Married women were more likely to 
have been screened at least once for cervical cancer than unmarried women as 81.6% of 
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the 49 respondents who screened for cervical cancer were married. Further, only those who 
had tertiary education had ever screened for cervical cancer (100%). Of note, the odds of 
having high knowledge were significant within groups based on their age group, marital 
status and level of education. Participants who were single in both groups were more likely 
than married participants, and those with tertiary education were more likely than the rest 
of the groups to have high knowledge of cervical cancer and cervical cancer screening. 
Similar to findings in another study that reported that the odds of screening for cervical 
cancer was 5.8 times more in women who had never been married and 3.3 times in married 
women (Mbachu, Dim, & Ezeoke, 2017). 
Limitations 
While the results of this study are very promising, there are some notable 
limitations. The study was conducted in urban setting, included only participants who can 
read and write in English, and most were college graduates. Further research is needed to 
validate the effectiveness of the educational intervention with a different population, 
setting, and with different socio-economic backgrounds. The use of a pre-post study design 
and relatively small sample size make it necessary for further research on larger sample 
using a rigorous research design. The use of immediate pre and posttest method limits the 
generalization of the result as the result reflects only short-term cognitive responses. Also, 
the participants were not followed up to ascertain their uptake of the preventive measures 
and considering that some studies reported poor uptake even with increase awareness, 
knowledge and willingness; it will be pertinent to investigate means to encourage uptake 
when other factors are positive. The changes overtime were not evaluated, hence the need 
for a longitudinal study. Further research should have multiple contacts with participants 
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and allow time for recollection of information and observe for uptake of the preventive 
measures. 
Another limitation is that while the content in both educational interventions was 
the same, emphasizing certain aspects of the content was more easily accomplished in the 
Presentation modality. For example, post-intervention knowledge of HPV infections being 
asymptomatic appears notably more improved in the Presentation Group. That difference 
might be attributed to the fact that the asymptomatic characteristic of HPV was repeatedly 
emphasized in during the presentation whereas it is stated only once in the pamphlet. Thus, 
the intervention strategies that were implemented could likely be further improved upon 
and tailored to more effectively deliver the health promotion messages.   
Conclusion 
These findings of this study, which measured outcomes of a community-based 
health education intervention using two educational strategies designed to increase 
knowledge and behavioral intent related to HPV vaccination and cervical screening, 
provides baseline evidence that low-cost interventions may increase awareness and 
knowledge. It is inevitably value-laden that credible evidence is required to reduce the gap 
between the health needs and resources available to respond to them.  These findings 
indicate that targeted health education (face-to-face presentation and printed pamphlet) are 
effective approach for improving HPV, cervical cancer and preventive measure awareness 
and knowledge, as well as improving intent to participate in HPV vaccination and 
screening services. To be effective, HPV health education programs should incorporate the 
knowledge, needs, interests, culture, values and beliefs of the target population and address 
issues across all levels of prevention. This study was unique in offering both detailed HPV 
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infection, cervical cancer and the preventive measures information to men and women 
living in urban settings. Earlier intervention studies in Nigeria have focused only on 
women, cervical cancer and screening, but this is the first to include men and combine 
HPV, cervical cancer and the preventive measures. We found that a large majority of men 
and women are willing to take and or encourage HPV vaccination and cervical cancer 
screening to their family and friends, if adequate information is provided to them, 
consistent with the literatures cited earlier.  
Considering the low research funding in developing nations, and the need to assess 
people living in hard to reach areas, the evidence has implications for public health 
planning and implementation. Relative to use of multiple educational strategies our finding 
suggests that educational interventions, delivered via print material or face-to-face group 
presentations may be low cost approaches that could be used by non-government and 
government programs in low resource settings. Importantly, study results suggest that 
group and individual educational strategies that deliver the same content may be effectively 
used to reach sub-sets of the population.  
Additionally, school-based vaccination may be another way to increase HPV 
vaccination. The sexual nature of HPV infection and the psychosocial factors related to 
STI, which may have profound effect on uptake vaccine and screening should be 
considered when planning interventions to improve uptake. Finally, the inclusion and 
participation of men in the study promotes the recommendation to mobilize and educate 
men as partners rather than barriers in women’s health. Evidence-informed approaches of 
including and working with men are needed to challenge several barriers influencing HPV 
vaccination and screening uptake, since men play huge roles in sexual and reproductive 
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health in SSA countries. Overall, the study findings lay the groundwork for further 
interventions to promote involvement of men in the reduction of HPV and cervical cancer 
in Nigeria.  
Recommendations 
Our findings indicate that increasing public understanding of the virus, its 
relationship with cervical cancer and the associated preventive measures are important 
steps to improve uptake. The study improved awareness, knowledge, as well as intent to 
take and/or encourage HPV vaccination and cervical cancer screening services. Replicating 
the study to see if increased knowledge and intention will translate into actual uptake of 
HPV vaccination and cervical cancer Screening. Due to our limited sample size, 
widespread implementation of at least two educational strategies among different 
geographic regions ethnic and religious populations across Nigeria would shed light on the 
long-lasting impact of HPV and cervical cancer education. Future research should compare 
HPV, cervical cancer and their preventive measures awareness, knowledge and intention 
across sexes in Nigeria in order to identify if there are significant differences in awareness, 
knowledge and intention. Additional investigations should be conducted among men or 
community male leaders only to see if it will mitigate most of the negative psychosocial 
barriers in Sub Sahara Africa. There is need for future longitudinal research to evaluate the 
effect of various interventions on increasing HPV vaccination and cervical cancer 
screening in Nigeria. Though this study was guided by two theories, future research is 
needed to use theory to inform the development of interventions. Lastly, it is important to 
develop evaluation and feedback tools to assess the effectiveness of the programs and to 
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be able to continuously improve the effectiveness of HPV vaccination and cervical cancer 
screening interventions and programs.  
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CHAPTER 4 
ADDRESSING STIGMA AND IMPROVING HPV AND CERVICAL CANCER 
KNOWLEDGE IN NIGERIA: ASSESSMENT OF A COMMUNITY-BASED 
EDUCATIONAL INTERVENTION 
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Introduction 
Human papillomavirus (HPV) is the most common viral infection of the 
reproductive tract, and a highly prevalent group of viruses among sexually active men and 
women worldwide (World Health Organization [WHO], 2018). HPV is mainly transmitted 
through sexual contact, but skin-to-skin genital contact is a well-established mode of 
transmission (WHO, 2018). The prevalence of HPV among the general population is 
unknown in Nigeria, but there are reports of a seroprevalence rate of 43% among women 
in the northern state of Birnin-Kebbi (Aminu et al., 2014). Others have reported HPV-IgG 
antibodies in over a quarter of the general population in Southern Nigeria (Bruni et al., 
2014; Okolo et al., 2010). Of note, Aminu and colleagues (2014) reported that the HPV 
infection was not significantly associated with women’s sexual behavior and found similar 
seroprevalence rates among women in both monogamous and polygamous marriages 
(Aminu et al., 2014). Furthermore, a link has been established between the HPV status of 
men and the risk of cervical cancer in their sexual partners (Bosch et al., 2002; Castellsagué 
et al., 2003). HPV is estimated to cause about 5% of human cancers (de Martel et al., 2012; 
Bosch et al, 2013); and found to be associated with the development of anogenital cancers 
(cervical, vaginal, vulvar, penile, and anal), oropharyngeal cancer, and genital warts (CDC, 
2017).  
Nigeria has one of the most extensive epidemics of cervical cancer in sub-Saharan 
Africa (Ferlay et al., 2014; Oguntayo et al., 2011), with a high incidence and mortality 
rates. Cervical cancer is the second most common female cancer in many parts of Nigeria 
(Oguntayo et al., 2011), and results in annual death of approximately 14,000 women 
(Ogundipe, 2013). Thus, on average, every hour one Nigerian woman dies of cervical 
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cancer (Ogundipe, 2013). The vast majority of cervical cancer cases are attributable to HPV 
infection, which are preventable. A comprehensive approach that includes prevention (i.e., 
HPV vaccination), effective screening (i.e., Pap smear, Visual Inspection with Acetic Acid 
[VIA] and HPV tests), early diagnosis, and treatment can significantly reduce the risks of 
HPV infection and cervical cancer. However, in Nigeria the uptake of these preventive 
approaches is low (Idowu, Olowookere, Fagbemi, & Ogunlaja, 2016; Wright et al., 2014). 
Among the majority of the Nigerian population there are low levels of HPV infection and 
cervical cancer knowledge (Ezenwa, Balogun, & Okafor, 2013; Ndikom & Ofi, 2012). 
Other barriers to cervical cancer screening include  lack of knowledge of the disease and 
screening techniques, stigma and modesty, and lack of spousal support (Lim & Ojo, 2017).   
This study was guided by the Theory of Gender and Power, which explores the 
depths of sexual inequity, gender and power imbalance (Connell, 1987). This theory further 
emphasizes social mechanisms that play an active role in maintaining in gender disparities 
and inequities in women’s lives. These inequalities and barriers can be economic, physical, 
social or personal in nature and operate at the interpersonal and individual levels. Each 
social structure constitutes different risk factors and exposures that increase Nigerian 
women’s vulnerability to HPV infection and cervical cancer. Spousal support in form of 
male involvement is important in addressing these exposures and risk factors (Wingood & 
DiClemente, 2000). Wingood and DiClemente (2000) applied Connell’s Theory of Gender 
and Power in their examination of HIV-related exposures, risk factors, and interventions, 
noting how gender-based inequities contribute to the generation of risk factors that 
adversely affect women’s health. Among these are gender discrimination, exclusion, 
labeling and stereotypes, which contribute to social stigma (Link & Phelan, 2001; 
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Trammell & Morris, 2012). The link between HPV, a sexually transmitted virus, and 
cervical cancer could contribute to stigmatization of cervical cancer and possibly to 
reluctance to receive HPV vaccine and cervical cancer screening. In their research with 
Chinese women in Hong Kong, Lee and colleagues (2007) noted that it was a difficult for 
their participants to accept the possibility that any sexual behavior could lead to HPV 
infection and subsequently to cervical cancer. Among women who tested positive for HPV 
during cervical screening, McCaffery and colleagues (2006) observed feelings of stigma 
and shame only when the women were aware that HPV is transmitted through sexual 
contact. 
The stigma associated with sexually transmitted infections (STI) may create 
barriers to information seeking, screening, and treatment (Fortenberry, 2004; Lim & Ojo, 
2017). Of note, a higher level of knowledge has been associated with less expressed stigma, 
especially in sexually transmitted infections like HIV (Exner et al., 2009). Furthermore, 
support from spouses or male community members can be a key motivation for increasing 
HPV vaccination and cervical cancer screening especially in male-dominated societies 
(Kim et al., 2012; Lim & Ojo, 2017; Lyimo & Beran, 2012). Despite men’s key role in 
reproductive and sexual health, HPV and cervical cancer programs in Nigeria have focused 
only on women, and to date, no research has examined the stigma-associated with HPV 
and cervical cancer. Interventions involving men and addressing stigma are urgently 
needed to improve awareness, spousal support, and reduce HPV and cervical cancer stigma 
in Nigeria. Therefore, one of the aims of this study was to examine the effectiveness of an 
educational intervention in improving knowledge of, and reducing stigma associated with, 
HPV and cervical cancer. A further aim was to identify and compare the differences 
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between men and women in Nigeria. The study was conducted in Anambra State. Anambra 
State the second most densely populated state in Nigeria, with an estimated 2013 
population of 5,366,900 (National Population Commission of Nigeria, 2015). A highly-
urbanized state, 62% of the population of Anambra is urban and literacy levels are high.  
Method 
The research aim was to evaluate the impact of an educational intervention on 
knowledge and stigma among a sample of urban-dwelling Nigerian men and women. The 
University of South Carolina Institutional Review Board reviewed and approved the 
research protocols on 12/4/2017. Inclusion criteria were men and women aged 18 to 65 
years who were able to read and write in English. Data collection spanned for four weeks 
from December 2017 and January 2018. The primary investigator personally recruited 
participants from 12 urban locations in Anambra, Nigeria (e.g., churches, businesses, 
healthcare institutions) and verbally explained the study purpose, eligibility criteria, 
confidentiality, and the voluntary nature of study participation to all potential participants. 
Participants recruited from churches and other organizations received information about 
the study from the priests, lay leaders, and organizational leaders. Nigeria is a country 
where faith has a substantial role with 87% of people reporting religious service attendance 
at least once a week, churches have been used effectively in health promotion interventions 
(Ezeanolue, et al., 2015; Ucheaga, & Hartwig, 2010; Abanilla, et al., 2010). 
Prior research has shown that increasing awareness and knowledge of HPV, HPV 
vaccination, and cervical cancer, and cervical cancer screening has been effective in 
increasing both behavioral intention and behavior, our aim was to implement an 
educational intervention that could be efficiently delivered to groups in natural settings 
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such as churches or delivered to individuals who may not be accessible in group settings. 
Based on the assumption that some members of the target population would be more 
accessible and/or amenable to a group intervention and others to an individual intervention, 
two different strategies for delivering the same health education content were employed to 
maximize population reach. Participants were given the opportunity to choose between 
attending an oral presentation or receiving printed materials.  
A total of 281 participants who met the inclusion criteria were enrolled to receive 
the intervention and almost 95% (n=266) completed the pretest, intervention and the post-
test. Only participants who completed the pre- and post-intervention surveys were included 
in the final analysis. The timing of the group presentations was coordinated with, and 
approved by, the officials at each site. Consistent with cultural norms in Nigeria, prior to 
data collection, the researcher obtained verbal informed consent, rather than written 
consent from all participants. Each study participant completed the self-administered paper 
questionnaire supplied by the researcher. The survey instrument used had been previously 
developed to assess the knowledge, attitude and practice of HPV and cervical cancer 
preventive measures among Nigerian men (Nkwonta and Messias, 2018) and was 
culturally modified to address gender issues within the context of Nigerian culture.  The 
original instrument was based on items from Cervical Cancer Free Coalition National 
Surveys, Health Information National Trends Survey and previous studies on HPV and 
cervical cancer among men in Ghana, Kenya and South Africa (Maree, Wright, & Makua, 
2011; Rosser, Zakaras, Hamisi, & Huchko, 2014; Rwamugira, Maree, & Mafutha, 2017; 
Williams, & Amoateng, 2012).  
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Intervention strategies. The community-based intervention was delivered as 
either a face-to-face health education presentation or a printed pamphlet, both containing 
identical information on HPV infection, cervical cancer, HPV vaccine and cervical cancer 
screenings. We developed the intervention content from the educational materials available 
on the Center for Disease Control and Foundation for Women’s Cancer websites (CDC, 
2017; Foundation for Women’s Cancer, 2017). We adopted and modified the presentation 
of the materials to make them more culturally and environmentally appropriate for the 
urban Nigerian population. Pre-intervention, all participants completed the demographic 
information section and the self-administered questionnaire consisting of multiple-choice, 
open and close-ended items. Subsequently participants either read the educational 
pamphlet or listened to an oral presentation by the investigator, followed by completion of 
the post-assessment survey.  
The educational content covered the following topics: (a) pictorial and introductory 
information on the HPV, including statistical facts of HPV incidence in Nigeria, (b) 
pictorial and introductory information on the cervix and cervical cancer, including 
statistical facts of cervical cancer incidence in Nigeria, (c) introduction of the HPV 
vaccination as a protective and preventive method for HPV infection and cervical cancer, 
(d) introduction of the cervical cancer screening as a preventive and early detection method 
for cervical cancer, (e) information on common misconceptions, (f) availability of HPV 
vaccination and cervical cancer screening in local pharmacies and hospitals, and (g) cost 
of vaccines and screenings. At post-test, all participants completed the same instrument. 
All sessions were personally conducted by the primary investigator.  
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Measures and Analysis. The primary outcomes of interest were knowledge of 
HPV, HPV vaccine, cervical cancer and cervical cancer screening, and stigma-associated 
with HPV and cervical cancer. We also collected sociodemographic information (i.e., age, 
marital status, education, and monthly income). Survey data were entered manually into 
two excel sheets and cross-checked for correctness. Statistical analysis was conducted 
using Statistical Analysis System (SAS) software version 9.4. Descriptive analysis (mean, 
frequency and percentage) were used to calculate the socio-demographics and compare the 
knowledge and stigma variables at pre-test and post-test. To assess for their level of 
knowledge, a composite score was computed for each respondent by assigning a score of 
0 to each wrong answer and 1 to each correct answer. Knowledge level was categorized as 
follows: low, 0-4; fair, 5-9; high, 10-13. T-tests were used to assess for significant 
differences in knowledge and stigma for both groups at pre-test and post-test. Logistic 
regression analysis was used to calculate the factors associated with knowledge and stigma 
associated with HPV and cervical cancer. Statistical significance was set at a p-value of 
<0.05.  
Results 
Only participants who took the pre- and post-test were included in the analysis. Of 
the 266 participants, 114 were men and 147 were women. There are differences in number 
of responses by topic because participants who have never heard of HPV and or cervical 
cancer were told to skip other HPV and cervical cancer knowledge questions. The sample 
of participants (Table 4.1) included nearly equal proportions of men and women with a 
mean age of 37.8 +11.1 for men and 36.1 +9.43 for women.  The dominant age groups 
were individuals between 24-34 and 35-44 years. The majority of the participants were 
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married and had tertiary education. There were no statistically significant differences 
between men and women in regard to participants’ age, age group, marital status or 
educational level. The participants’ monthly income differed significantly by gender, with 
more than half the women (56.9%) earning less than 50, 000 Nigerian Naira every month. 
Table 4.1: Summary of participants’ characteristics  
Characteristic Men n(%) Women n(%) T test 
Age, years (mean+SD) 37.8 +11.1 36.1 +9.43 0.2032 
Age group (years)    
18 -24 4 (3.51) 4 (2.72)  
25 - 34     47 (41.2) 67 (45.6) 0.3065 
35 - 44       34 (29.8) 46 (31.3)  
45 - 54       18 (15.8) 23 (15.7)  
55 and above  11 (9.65) 7 (4.76)  
Marital status     
Single 46 (40.4) 49 (32.5) 0.1887 
Married 68 (59.7) 102 (67.5)  
Educational level    
No formal education 1 (0.88)   
Primary education  3 (2.63) 1 (0.67) 0.5222 
Secondary education  23 (20.2) 34 (22.7)  
Tertiary education  87 (76.3) 115 (76.7)  
Monthly income    
Less than #50, 000 39 (36.1) 83 (56.9) 0.0005 
#50-100,000 31 (28.7) 35 (24.0)  
Above #100,000 38 (35.2) 28 (19.2)  
 
Awareness and Knowledge of HPV, Cervical Cancer and the Screening 
Measures. Table 4.2 presents data related to participant awareness and knowledge of HPV 
and cervical cancer. At baseline, the majority of the men (62.6%) and women (70.2%) had 
never heard of HPV; which was reduced to less than 4% at post-intervention; there was no 
statistical difference between the two groups (p=0.2659). Similarly, at baseline few 
participants (30.2% of men and 25.8% of women) knew that HPV is sexually transmitted, 
but at post-intervention, the clear majority of men (95%) and women (94%) had attained 
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this knowledge (p <0.05). In terms of knowledge regarding susceptibility to contracting 
HPV, there was a significant difference observed between baseline (p >0.05) and post 
intervention (p <0.05) responses. Pre-intervention awareness of HPV vaccine was very low 
and differed between the two groups (p=0.0055), with 72.6% of men and 84.8% of women 
not aware of HPV vaccine. Post-intervention, lack of awareness was less than 10% in both 
groups. Furthermore, knowledge of the appropriate age group for HPV vaccine went from 
less than 14% at pre-test to 60% at post-intervention in both groups, with no statistically 
significant difference between groups (0.9653).  
Table 4.3 presents the data related to pre- and post-intervention cervical cancer 
awareness and knowledge. There were significant increases in all the measures of cervical 
cancer awareness and knowledge. In contract to the awareness and knowledge of HPV and 
HPV vaccine, a majority of the participants were aware of cervical cancer. At baseline, 
more than 72% and 62% of men and women were aware of cervical cancer, but less than 
58% knew that having multiple sexual partners increase the risk of getting cervical cancer. 
At baseline there were statistically significant differences in level of awareness of the risk 
factors for cervical cancer (0.0043), awareness of cervical cancer being caused by an 
infection (0.0073), and awareness of HPV infection as the major cause of cervical cancer 
(0.0005) but no statistical differences at post intervention (p>0.05 for all). Although the 
majority of the participants were aware of cervical cancer at baseline, very few (20.2% of 
men and 24.5% of women) were aware of any type of cervical cancer screenings. After the 
targeted educational intervention, awareness of cervical cancer screening increased to 
76.5% in men and 80.8% in women (0.0245).  
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Table 4.2: Participants Knowledge of HPV and HPV Vaccine 
Variables  Pre-Intervention n(%) Post-Intervention n(%) 
 Men Women p Men Women P 
Have you ever heard 
of HPV?                No        
Yes 
Not sure 
 
72(62.6) 
31(27.0) 
12(10.4) 
 
106(70.2 
26(17.2) 
19(12.6) 
 
 
0.5255 
 
4(3.38) 
110(95.7) 
1(0.87) 
 
5(3.31) 
140(92.7) 
6(3.97) 
 
 
0.2659 
How do you think one 
can get HPV?  
Physical contact  
Dirty toilets  
Poor personalhygiene 
Sexual intercourse 
 
 
7(6.09) 
7(6.09) 
8(6.96) 
35(30.2) 
 
 
1(0.66) 
7(4.64) 
12(7.95) 
39(25.8) 
 
 
0.0217 
0.6075 
0.7607 
0.4114 
 
 
14(12.4) 
2(1.74) 
8(6.96) 
110(95.7) 
 
 
9(5.96) 
15(9.93) 
13(8.61) 
142(94.0) 
 
 
0.0809 
0.0030 
0.6175
0.5535 
How do you know 
when someone has 
HPV?                 Itching  
Pain during urination 
Genital discharges 
Genital rash 
No symptoms 
 
 
20(17.4) 
7(6.09) 
13(11.3) 
20(17.4) 
10(8.70) 
 
 
8(5.30) 
6(3.97) 
16(10.6) 
8(5.30) 
13(8.61) 
 
 
0.0028 
0.4429 
0.8556 
0.0028 
0.9803 
 
 
12(10.4) 
13(11.3) 
31(27.0) 
16(13.9) 
65(56.5) 
 
 
23(15.2) 
17(11.3) 
56(37.1) 
16(10.6) 
71(47.0) 
 
 
0.2430 
0.9907 
0.0783 
0.4195 
0.1253 
Who can contract 
HPV?            Male only 
Female only 
Male and female 
 
9(9.38) 
11(11.5) 
32(33.3) 
 
0 
9(9.38) 
35(36.5) 
 
 
0.0056 
 
2(1.80) 
12(10.8) 
97(87.4) 
 
0 
7(4.79) 
139(95.2) 
 
 
0.0233 
What factors increase 
the risk of getting 
HPV?             Poor diet  
Smoking 
Poor personalhygiene  
Many sexual partners  
 
 
6(5.22) 
4(3.48) 
12(10.4) 
32(27.8) 
 
 
0(0) 
14(9.27) 
7(4.64) 
40(26.5) 
 
 
0.0137 
0.0487 
0.0840 
0.8094 
 
 
2(1.74) 
37(32.2) 
14(12.3) 
102(89.5) 
 
 
5(3.31) 
52(34.4) 
16(10.6) 
137(90.7) 
 
 
0.4103 
0.6991 
0.6726 
0.7371 
Tick the disease you 
think HPV can cause?  
Cancer of Anus 
Cancer of cervix 
Genital warts 
Cancer of Penis 
Cancerofmouth/throat 
Cancer of Vagina 
 
 
7(6.09) 
27(23.5) 
14(12.1) 
4(3.51) 
9(7.83) 
12(10.4) 
 
 
7(4.64) 
33(21.9) 
10(6.62) 
9(5.96) 
11(7.28) 
12(7.95) 
 
 
0.6075 
0.7555 
0.1324 
0.3456 
0.8695  
0.4922 
 
 
65(56.5) 
89(77.39) 
30(26.6) 
69(60.5) 
56(48.7) 
63(54.8) 
 
 
69(45.7) 
124(82.1) 
39(25.8) 
72(47.7) 
66(43.7) 
91(60.5) 
 
 
0.0807 
0.3467 
0.8957 
0.0377 
0.4212  
0.3728 
Have you heard about 
HPV vaccine?          No                    
Yes  
Not sure 
 
82(72.6)
20(17.7) 
11(9.73) 
 
128(84.8 
20(13.3) 
3(1.99) 
 
 
0.0055 
 
12(10.4) 
98(85.2) 
5(4.35) 
 
13(8.72) 
133(89.3) 
3(2.01) 
 
 
0.8879 
Who can take the 
vaccine?  
Boys & girls  
Young men & women  
 
 
8(6.96) 
19(17.0) 
 
 
21(13.9) 
26(17.2) 
 
 
0.0611 
0.9570 
 
 
69(60.0) 
77(67.0) 
 
 
91(60.3) 
92(60.9) 
 
 
0.9653 
0.3110 
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Table 4.3. Knowledge of Cervical Cancer and Cervical Cancer Screening 
Variables  Pre-Intervention n(%) Post-Intervention n(%) 
 Men Women p Men Women P 
Have you ever heard 
of cervical cancer?                                     
No  
Yes 
Not sure 
 
24(21.1) 
83(72.8) 
7(6.14) 
 
35(23.2) 
95(62.9) 
21(13.9) 
 
 
 
0.4076 
 
 
3(2.65) 
106(93.8 
4(3.54) 
 
 
2(1.34) 
138(92.6 
9(6.04) 
 
 
 
0.2374 
Which of the following 
do you think increases 
the risk of getting 
cervical cancer?  
Smoking 
Multiple sexual 
partners 
 
 
 
 
26(22.6) 
46(40.0) 
 
 
 
 
40(26.5) 
87(57.6) 
 
 
 
 
0.4665 
0.0043 
 
 
 
 
42(36.5) 
94(81.7) 
 
 
 
 
71(47.0) 
134(88.7 
 
 
 
 
0.0854 
0.1166 
Do you think cervical 
cancer is associated 
with an infection?    No 
Yes 
 
 
4(43.7) 
58(56.3) 
 
 
38(27.0) 
103(73.0 
 
 
0.0073 
 
 
7(6.36) 
103(93.6 
 
 
10(6.67) 
140(93.3 
 
 
0.9223 
If yes; what type of 
infection is cervical 
cancer associated 
with?       
HPV infection 
 
 
 
 
30(26.1) 
 
 
 
 
69(46.6) 
 
 
 
 
0.0005 
 
 
 
 
96(83.5) 
 
 
 
 
136(90. 
 
 
 
 
0.2614 
Cervical cancer be 
prevented?              No 
Yes     
 
17(16.0) 
89(84.0) 
 
15(10.3) 
130(89. 
 
0.1961 
 
4(3.60) 
107(96.4 
 
5(3.38) 
143(96.6 
 
0.9227 
Early detection of 
cervical cancer is 
helpful?                  No 
                              Yes 
 
 
8(7.55) 
98(92.5) 
 
 
12(8.11) 
136(91.9 
 
 
 
0.8700 
 
 
3(2.73) 
107(97. 
 
 
4(2.78) 
140(97.2 
 
 
 
0.9806 
Have you heard about 
Pap smear test or 
Visual Inspection with 
Acetic Acid (VIA)?                 
No  
Yes  
Not sure 
 
 
 
74(64.9) 
23(20.2) 
17(14.9) 
 
 
 
 
94(62.3) 
37(24.5) 
20(13.3) 
 
 
 
 
 
0.9132 
 
 
 
 
11(9.57) 
88(76.5) 
16(13.9) 
 
 
 
 
21(13.9) 
122(80.8 
8(5.30) 
 
 
 
 
 
0.0245 
Have you heard about 
HPV test?               No              
Yes 
Not sure 
 
68(60.2) 
24(21.2) 
21(18.6) 
 
106(70.2 
32(21.2) 
13(8.61) 
 
 
0.0284 
 
7(6.14) 
100(87.7 
7(6.14) 
 
14(9.40) 
126(84.6 
9(6.04) 
 
 
0.4670 
Who can take Pap 
smear test or VIA or 
HPV test?          Women 
 
 
33(29.0) 
 
 
64(42.4) 
 
 
0.0229 
 
 
94(81.7) 
 
 
135(89. 
 
 
0.0833 
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Level of Knowledge of HPV, and Cervical Cancer. Table 4.4 presents data on 
the level of HPV and cervical cancer knowledge. Overall, prior to the educational 
intervention, respondents’ level of knowledge of HPV, and cervical cancer were low, but 
improved at post-test. The majority of participants (81.7% of men and 84.7% of women) 
had poor knowledge of HPV and HPV vaccine at baseline. Following the intervention, 
participants’ knowledge significantly improved, with poor knowledge persisting among 
less than 13%, while nearly 50% had high HPV-related knowledge. At pre-intervention, 
the level of cervical cancer knowledge among men and women was significantly different 
(0.0012), with no significant differences at post-intervention.  
Table 4.4: Participants’ Level of Knowledge of HPV, HPV Vaccine, Cervical Cancer and 
Cervical Cancer Screening Pre-Intervention and Post-Intervention  
Variables  Pre-Intervention n (%) Post-Intervention n (%) 
 Men Women p Men Women p 
Level of Knowledge 
of HPV and HPV 
Vaccine. 
Poor 
 Moderate 
High  
 
 
 
94(81.7) 
17(14.8) 
4(3.48) 
 
 
 
127(84.7) 
13(8.67) 
10(6.67) 
 
 
 
0.9677 
 
 
 
14(12.2) 
39(33.9) 
62(53.9) 
 
 
 
19(12.6) 
57(37.8) 
75(49.7) 
 
 
 
0.5916 
Level of Knowledge 
of Cervical Cancer 
and Cervical Cancer 
screening?     
Poor                                                
Moderate 
High  
 
 
 
 
46(40.0)
40(34.8) 
29(25.2) 
 
 
 
 
39(25.8)
46(30.5) 
66(43.7) 
 
 
 
 
0.0012 
 
 
 
 
11(9.57) 
19(16.5) 
85(73.9) 
 
 
 
 
4(2.65) 
26(17.2) 
121(80.1) 
 
 
 
 
0.0702 
 
Stigma Associated with HPV Infection and Cervical Cancer. In terms of stigma 
(see Table 4.5), no significant changes were observed pre/posttest in five out of the six 
domains; however, there were no statistically sig differences except for “Do you believe 
telling someone you have (had) cervical cancer is risky”. Some participants moved from 
uncertainty (i.e., “not being sure”) at pre-test to blaming or stigmatizing victims at post-
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test. For example, at pre-test, 11.5% of men and 16.6% of women indicated testing positive 
to HPV infection was associated with having multiple sex partners. However, at post-test, 
33.9% of men and 32.5% of women agreed that a positive HPV test result did mean the 
person had multiple sex partners. Similar response trends were noted in relation to the 
perception of individuals with cervical cancer as having had multiple sexual partners.  
Of note, gendered perceptions of disclosure of having cervical cancer were not very 
different before the intervention but became statistically significant (0.0394) after the 
intervention. At pre-test, 20.2% of men and 35.1% of women agreed disclosing ones’ status 
is risky, whereas following the educational intervention, 31.3% of men and 43.1% of 
women agreed that it is risky for an individual to disclose their status.  
Factors associated with high knowledge of HPV and cervical cancer. The 
results of logistic regression analyses on knowledge of HPV and HPV vaccine at post 
intervention (Table 4.6). The odds of high knowledge of HPV and HPV vaccine is 3.4 
times for male participants (ages 45-54) than the odds of high knowledge of HPV and HPV 
vaccine for participants who are 55 years and above. The adjusted odds of having high 
knowledge of HPV and HPV vaccine is 1.7 times for male single participants and 2.4 times 
for those who earn more than 100,000 naira than the odds of married participants and those 
who earned less than 50,000 naira respectively. These categories were found to be 
statistically different. However, no statistically significant differences were observed based 
on their age group, marital status, education and income for the women. 
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Table 4.5. Stigma Associated with HPV Infection and Cervical Cancer 
Variables  Pre-Intervention n(%) Post-Intervention n(%) 
 Men Women p Men Women p 
Do you think people 
with HPV infection 
sleep with a lot of 
different people?                                          
No  
Yes 
Not sure 
 
 
 
22(19.5) 
13(11.5) 
78(69.0) 
 
 
 
34(22.5) 
25(16.6) 
92(60.9) 
 
 
 
 
 
0.2729 
 
 
 
 
35(30.4) 
39(33.9) 
41(35.7) 
 
 
 
 
43(28.5) 
49(32.5) 
59(39.0) 
 
 
 
 
 
0.5948 
Do you think people 
with cervical cancer 
sleep with a lot of 
different people?                                          
No  
Yes 
Not sure 
 
 
 
30(26.5) 
15(26.5) 
68(60.2) 
 
 
 
46(30.5) 
16(10.6) 
89(58.9) 
 
 
 
 
 
0.6407 
 
 
 
 
43(37.4) 
33(28.7) 
39(33.9) 
 
 
 
 
47(31.1) 
40(26.5) 
64(42.4) 
 
 
 
 
 
0.1624 
Do you think people 
who have (had) 
cervical cancer caused 
their problem?                                       
No  
Yes 
Not sure 
 
 
 
 
43(37.7) 
7(6.14) 
64(56.1) 
 
 
 
 
67(44.4) 
20(13.3) 
64(42.4) 
 
 
 
 
 
0.0835 
 
 
 
 
52(45.2) 
26(22.6) 
37(32.20 
 
 
 
 
58(38.4) 
41(27.2) 
52(34.4) 
 
 
 
 
 
0.3982 
Do you think that a 
person affected by 
cervical cancer is 
disgusting?  
No 
Yes 
Not sure 
 
 
 
 
59(51.8) 
10(8.77) 
45(39.5) 
 
 
 
 
66(43.7) 
28(18.5) 
57(37.8) 
 
 
 
 
 
0.5848 
 
 
 
 
74(64.4) 
10(8.70) 
31(27.0) 
 
 
 
 
87(57.6) 
23(15.2) 
41(27.1) 
 
 
 
 
 
0.5245 
Do you feel 
uncomfortable around 
someone affected by 
cervical cancer?                                         
No  
Yes 
Not sure 
 
 
 
48(42.1) 
17(14.9) 
49(43.0) 
 
 
 
67(25.3) 
37(14.0) 
47(31.1) 
 
 
 
 
 
0.2068 
 
 
 
 
62(54.4) 
20(17.5) 
32(28.1) 
 
 
 
 
80(53.0) 
30(20.0) 
41(27.2) 
 
 
 
 
 
0.9639 
Do you believe telling 
someone you have 
(had) cervical cancer is 
risky? 
No  
Yes  
Not sure 
 
 
 
 
51(44.7) 
23(20.2) 
40(35.1) 
 
 
 
 
53(35.1) 
53(35.1) 
45(29.8) 
 
 
 
 
 
0.6826 
 
 
 
 
54(47.0) 
36(31.3) 
25(21.7) 
 
 
 
 
47(31.1) 
65(43.1) 
39(25.8) 
 
 
 
 
 
0.0394 
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Table 4.6: Regression Analysis of Factors Associated with High Knowledge of HPV and 
HPV Vaccination at Post Intervention 
 Men   Women  
 Odds 
Ratio 
95% CI for OR Odds 
ratio  
95% CI for OR 
Lower  Upper  Lower  Upper  
Age group 
18 - 24      
25 - 34  
      35 - 44  
      45 - 54  
      55+ (referent)  
Marital status 
            Single 
Married (referent) 
Education Level 
No formal education  
Primary education  
Secondary education 
Tertiary education 
(referent) 
 
Monthly income 
(Nigerian Naira) 
    Less ₦50,000 (referent)   
 ₦50-100,000 
Above ₦100,00  
 
0.3739 
0.8051 
1.6675 
3.4232 
 
 
1.7276 
 
 
1292187 
0.1805 
0.6113 
 
 
 
 
 
0.8099 
2.4497 
 
0.05972 
0.4656 
0.8422 
1.1402 
 
 
1.0622 
 
 
0 
0.02102 
0.9522 
 
 
 
 
 
 
0.4135 
1.2222 
 
2.3408 
1.3921 
3.3017 
10.2775 
 
 
2.8098 
 
 
Infty 
1.5507 
1.3259 
 
 
 
 
 
 
1.5865 
4.9099 
 
3.1758 
0.7361 
1.0653 
1.7584 
 
 
1.1548 
 
 
 
1.632E-7 
0.9694 
 
 
 
 
 
 
1.0108 
1.7922 
 
0.3236 
0.4640 
0.6087 
0.7613 
 
 
0.7892 
 
 
 
0 
0.5081 
 
 
 
 
 
 
0.5334 
0.8367 
 
31.1711 
1.1678 
1.8645 
4.0614 
 
 
1.6898 
 
 
 
Infty 
1.8498 
 
 
 
 
 
 
1.9154 
3.8388 
 
Regarding knowledge of cervical cancer and cervical cancer screening at post 
intervention (Table 4.7), for participants aged 35-44, the odds of high knowledge 
of cervical cancer and cervical cancer screening is 3.6 times for men and 8.1 times for 
women than the odd of high knowledge for men and women who were 55 years and above. 
Additionally, men had 1.9 times and women had 3.5 times the odds of high knowledge 
of cervical cancer and cervical cancer screening than the participants aged 55 years and 
above. In terms of marital status, a significant difference was observed. The odds of high 
knowledge of cervical cancer and cervical cancer screening for single male participants 
 87 
were 2.1 times and 4 times for single female participants than the odds for married 
participants.  
Table 4.7: Logistic Regression Estimates (Odds Ratio) of High Knowledge of Cervical 
Cancer at Post Intervention. 
 Men   Women  
 Odds 
Ratio 
95% CI for OR Odds 
ratio  
95% CI for OR 
Lower  Upper  Lower  Upper  
Age group 
18 - 24      
25 - 34  
      35 - 44  
      45 - 54  
      55+ (referent)  
Marital status 
            Single 
Married (referent) 
Education Level 
No formal education  
Primary education  
Secondary education 
Tertiary education (referent) 
 
Monthly income (Nigerian 
Naira) 
    Less ₦50,000 (referent)   
 ₦50-100,000 
Above ₦100,00  
 
0.4189 
1.9317 
3.6420 
1.7506 
 
 
2.1985 
 
 
2245761 
0.2192 
1.1797 
 
 
 
 
 
2.1751 
4.3848 
 
0.06733 
1.0640 
1.6136 
0.5236 
 
 
1.1863 
 
 
0 
0.02544 
0.5326 
 
 
 
 
 
1.0283 
1.9412 
 
2.6069 
3.5068 
8.2204 
5.8533 
 
 
4.0745 
 
 
Infty 
1.8882 
2.6130 
 
 
 
 
 
4.6005 
9.9047 
 
3.2182 
3.5477 
8.1928 
6.8627 
 
 
4.0408 
 
 
 
0.4258 
2.4383 
 
 
 
 
 
6.0326 
6.2316 
 
0.3258 
1.9945 
3.2415 
2.0162 
 
 
2.0076 
 
 
 
0.01135 
1.1708 
 
 
 
 
 
2.3406 
2.1353 
 
31.7851 
6.3105 
20.7074 
23.3600 
 
 
8.1331 
 
 
 
15.9670 
5.0780 
 
 
 
 
 
15.5482 
18.1865 
 
Discussion 
To the best of our knowledge, this study is the first in Nigeria to compare the 
efficacy of an educational intervention in improving levels of awareness and knowledge 
of HPV, HPV vaccine, cervical cancer and cervical cancer screening among men and 
women and to examine the effect of an educational intervention on stigma associated 
with HPV and cervical cancer. These findings indicate that community-based health 
education, whether delivered to groups or to individuals, is a promising strategy to 
increase HPV and cervical cancer awareness and knowledge among urban-dwelling 
 88 
Nigerian men and women. Similar to prior research conducted in other regions of Nigeria 
and other countries in sub-Saharan Africa, at pre-intervention we observed low levels of 
awareness and knowledge of HPV, cervical cancer and preventive measures (Gana et al., 
2016; Odunyemi, Ndikom, & Oluwatosin, 2018; Rwamugira, Maree, & Mafutha, 2017; 
Williams & Amoateng, 2012). A study in Singapore found that only 16% of the sample 
of men had ever heard of the HPV (Pitts, et al., 2009). Increased awareness and 
knowledge of HPV infection is vital for both men and women, given the significant health 
complications of HPV infection in both groups.  
Of note, post-intervention awareness and knowledge improved remarkably among 
both men and women, with more than 80% correctly answering specific questions about 
the risk factors, mode of transmission, and the preventive methods at post-test. Similarly, 
Adamu et al., (2012) examined the impact of health information on knowledge of cervical 
cancer in North-Western Nigeria and reported a significant difference (p<0.001) in 
knowledge with a mean score 63.7% among female teachers who participated in the 
intervention. Following a nurse-led educational intervention in Abuja, Nigeria, Odunyemi 
and colleagues (2018) reported a significant increase (mean score 9.6 ± 7.2 to 21.5 ± 6.2) 
in cervical cancer and HPV knowledge. Prior to the educational intervention, 83.4% of the 
participants had poor knowledge of HPV and HPV Vaccine, compared to 12.4% following 
the intervention, and those with good knowledge increased from 5.28% to 51.5% 
(p <.0001). Among participants with poor knowledge of cervical cancer and cervical 
screening, the proportion reduced from 32% to 5.64%, whereas those with very good 
knowledge increased from 35.7% to 77.4% (p < 0.0001).  
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Community members’ knowledge of the association of HPV as a STI sexually 
transmitted infection may impede cervical cancer prevention efforts. The stigma associated 
with STIs is increasingly recognized as a critical psychosocial element that may affect 
uptake of preventive measures. A study among men in Ghana, found that the most common 
belief was that cervical cancer is caused by frequent sex resulting in physical damage 
(Williams & Amoateng, 2012). Of note, the proportion of participants in this community-
based research who associated testing positive for HPV infection with having had multiple 
sex partners increased significantly after the intervention in both groups, as did the 
perception of women diagnosed with cervical cancer. This is similar to the finding by 
Fernandez, et al., (2009), who noted men reported they would suspect infidelity by their 
partner, if their partner told them she was HPV positive. They also noted that even with 
increased understanding that men’s own infidelity could be the cause of their partner's 
infection, most men still stated that their first reaction would be to question the woman's 
faithfulness. 
Of further note is the post-intervention increase of men and women who indicated 
individuals with cervical cancer had caused their own problem increased after the 
intervention. These findings are consistent with previous research linking awareness of 
HPV as sexually transmitted with significantly higher levels of stigma and shame 
(McCaffery et al., 2006; Waller, et al., 2007). Similarly, research by Shepherd and Gerend 
(2014) reported participants rated a patient with cervical cancer as more dirty, dishonest 
and unwise when the cause of the cancer was specified than when it was not specified. The 
findings from this research suggest the risk that raising awareness of HPV as a sexually 
transmitted infection may potentially increase feelings of stigma and shame among those 
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infected. The increased stigma observed in this study indicate that most of the participants 
are in Stage 2, unengaged, and stage 3, decision making time, of the Precaution Adoption 
Process Model. This means there are significant gaps in their knowledge about HPV and 
cervical cancer, including risk and protective factors. Specifically, continuing 
dissemination of appropriate, culturally tailored and scientifically sound information 
among diverse groups could contribute to the reduction of stigma associated with HPV and 
cervical cancer, which over time could contribute to better health outcomes. 
Stigma associated with lack of information is a common barrier to disclosure, 
particularly in relation to information with sexual connotations. An individual’s ability and 
willingness to disclose their status is dependent on the societal perception and feeling 
toward HPV and cervical cancer. Following the educational intervention, respondents’ 
perceptions regarding the risk of disclosing to others that they have cervical cancer 
increased in both groups, with more women not being willing to disclose their status. Our 
finding revealed a statistically significant difference by gender in some of the key questions 
such as who can contract HPV and knowledge of HPV vaccine and cervical cancer at both 
preintervention and postintervention. More women than men had more stigmatized belief 
about disclosing of status.  In contrast, Perrin and colleagues (2006) reported that the 
majority (65%) of the women in their study had disclosed their HPV diagnosis to at least 
one other person. The finding may be due to internalized stigma associated with social 
expectation of women in Nigeria and the patriarchal culture of the society. A permanent 
change in awareness, knowledge and stigma associated with HPV and cervical cancer may 
be achieved by adequate and sustained health education programs with or without other 
interventions. Several strategies for stigma reduction tailored at intrapersonal, 
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interpersonal, community and organizational/institutional level are reported in the 
literature (Heijnders, & Van Der Meij, 2006; Stangl et al., 2013). These strategies include 
counselling, cognitive behavioral therapy, self-help, advocacy and support groups (Stangl 
et al., 2013). 
Conclusion  
Awareness, knowledge, perceptions, and attitudes contribute to women’s exposure 
to and susceptibility to HPV infection, and subsequently, to cervical cancer.  In Nigeria, 
given the high prevalence of HPV infection, there is an associated high prevalence of 
cervical cancer. An increase in HPV and cervical cancer morbidity and mortality have 
contributed to the urgent need to scale up HPV vaccine and cervical screening efforts. This 
research assessed the effectiveness of a community-based educational interventions in 
improving HPV awareness and knowledge among urban-dwelling Nigerian men and 
women. The untoward finding of increased stigma associated with HPV and cervical 
cancer following the educational intervention is not surprising, given that HPV is a sexually 
transmitted virus, and as such may be associated with stigma. Given that stigma is a 
possible hindrance to the uptake of HPV vaccine and screening, there is an urgent need for 
implementing culturally tailored stigma reduction interventions at intrapersonal, 
interpersonal, community and organizational/institutional to combat stigma associated 
with HPV and cervical cancer. To reduce the negative connotations associated with the 
HPV virus using health education, public information should focus on the cause of the 
condition, asymptomatic nature of HPV infection, its widespread prevalence, and the fact 
that most sexually active people will contract HPV at some point in their lives.  
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Limitations 
There are several limitations to the methods and implications of this research. We 
used a self-administered survey to assess the impact of this tailored, community-based 
educational intervention and therefore were not able to identify any causal relationships 
between knowledge, attitudes, or practices overtime. Furthermore, the nature of the 
convenience sampling and urban setting limits generalizability to the larger Nigerian adult 
population. Of note, the majority of the participants were college educated, which is not 
representative of the general Nigerian population. Given the research included only 
participants who can read and write in English, the sample also does not reflect non-English 
speaking Nigerians.   
Recommendations for further research  
Educational interventions are effective at improving awareness, knowledge and 
willingness to participate in preventive and screening services among diverse populations. 
However, educational interventions do not necessarily remove or ameliorate structural 
barriers to uptake of preventive and screening services. There is a need for further 
exploration of the effectiveness of targeted educational interventions in improving HPV 
and cervical cancer-related stigma in different circumstances, contexts and settings in SSA. 
Further research is warranted to explore and uncover stigma and other emotional factors 
that may influence HPV vaccination and screening utilization. It is important to assess HPV 
knowledge and attitudes among diverse groups of Nigerian women, men, healthcare 
providers and community leaders. To examine sources of stigma and develop culturally-
tailored strategies to combat the stigma, further research with larger samples of married 
men, unmarried men in heterosexual relationship(s) and male community leaders is 
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warranted. There is also a need for further research to identify other educational 
interventions and approaches to increase male involvement in HPV and cervical cancer 
prevention, not only in Nigeria, but in other countries and cultures. 
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CONCLUSION AND RECOMMENDATIONS 
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Conclusion  
The findings from this study support that health education is an effective tool for 
increasing awareness, enhancing knowledge and encouraging willingness to engage in 
HPV vaccination and screening services among Nigerian adults. Among the 266 urban-
dwelling Nigerian adults who participated in the study, the majority had low levels of 
knowledge of HPV and HPV Vaccine at baseline. However, after exposure to the 
community-based educational intervention, knowledge levels clearly increased. Of note, 
very few of the 266 participants reported having received the HPV vaccine or having a 
family member who had been vaccinated or screened for HPV. Following exposure to the 
community-based, culturally tailored educational intervention, there was a clear increase 
in reported intent to be vaccinated take and to encourage a family member to receive HPV 
vaccination and cervical cancer screening. Of note are the findings related to negativity in 
relation to HPV and cervical cancer stigma. We observed negative perception about HPV 
and cervical cancer increased with increased knowledge of HPV and cervical cancer. This 
may be due to increased awareness on sexual nature of HPV infection, as sexually 
transmitted virus has a relationship with stigma. Therefore, increased continuing and 
sustained public education on the asymptomatic nature of HPV, its prevalence and that 
most sexually active people will contract HPV at some point in their life may help reduce 
the negative feeling associated with the virus. 
 Unique aspects of this research were the inclusion of information on HPV 
infection, cervical cancer and the preventive measures to both men and women in urban 
settings. Earlier intervention studies in Nigeria have focused solely on women and cervical 
cancer and screening (Adamu, Abiola, & Ibrahim, 2012; Abiodun, Olu-Abiodun, Sotunsa, 
& Oluwole, 2014; Chigbu, Onyebuchi, Onyeka, Odugu, & Dim, 2017; Gana, Oche, Ango, 
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Raji, & Okafoagu, 2016; Mbachu, Dim, & Ezeoke, 2017; Wright, Kuyinu, & Faduyile, 
2010; Ndikom et al, 2017; Ndikom, Ofi, Omokhodion & Adedokun, 2017; Odunyemi, 
Ndikom, & Oluwatosin, 2018). This research is the first to include men and have a 
combined focus on HPV infection, cervical cancer and specific preventive measures (i.e., 
HPV vaccination). Incorporating educational initiatives into community-based, non-
governmental and government-sponsored programs will lead to both increased awareness 
and uptake of preventive measures. Other strategies to increase HPV vaccination include 
school-based and workplace vaccination opportunities. Possible deterrents to HPV 
immunization uptake include the sexual nature of HPV infection and the psychosocial 
factors related to sexually transmitted diseases. Health educators and healthcare 
professionals must consider these cultural and social factors in planning interventions to 
improve HPV immunization uptake.  
Of particular note was the importance of men’s participation in this research. This 
study serves as an example of the importance of mobilizing and educating men as partners 
rather than barriers in relation to women’s health issues. Given men’s roles and influence 
in sexual and reproductive health access in SSA, further evidence-informed approaches 
that include men as active participants and partners are needed to challenge the multiple 
social, economic, and cultural barriers to HPV vaccination and screening uptake. The 
findings of this study lay the groundwork for further research-based interventions to 
promote involvement of men in the reduction of HPV and cervical cancer in Nigeria. This 
study utilized the Theory of Gender and Power, applied to the men and women living in 
Anambra. Caution should be taken when generalizing the results to other Nigerians. More 
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research is needed to identify the most effective theory-based interventions for evidence-
based nursing practice in this population. 
Implications for Nursing Practice 
Given that nurses are in a position to effect change and to promote healthy 
preventive practices, the study findings are relevant to nursing practice, research and 
policy. The positive impact of this targeted educational intervention in improving 
awareness, knowledge and intention to take HPV vaccine and cervical cancer screening 
among urban Nigerian men suggests that similar initiatives should be developed for other 
populations and settings. However, nurses and nurse researchers also need to pay attention 
to the gaps in the HPV knowledge, lack of uptake of preventative practices, and stigma 
regarding HPV and cervical cancer, in order to develop and implement culturally focused 
and tailored interventions to improve HPV vaccine and cervical cancer screening among 
diverse populations and settings in Nigeria. Nurses need to be aware of the clinical 
implications for population and be prepared to inform and educate both men and women 
in Nigeria.  
At the individual level, these findings may help inform nursing interventions with 
female patients who lack the ability to make health decisions and influence decision 
making by involving their significant others. Also, discussing the patient’s beliefs related 
to HPV and cervical cancer and perceptions of vulnerability may contribute to reducing the 
social stigma related to these diseases. Nurses can facilitate HPV vaccination and screening 
uptake by participating in community health events and providing home visits.  
Recommending and communicating accurate information to patients is an important role 
for nurses. With ongoing rural to urban and international migration, it is important to 
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incorporate knowledge of new cultures and languages into nursing curriculums, at both the 
baccalaureate and graduate levels, and to expose practicing nurses to various cultures and 
sociocultural factors influencing health and illness. More research on HPV and cervical 
cancer screening and the application of the Theory of Gender and Power among the 
Nigerian population is needed. The current study provided information about the 
applicability of the Precaution Adoption Process Model and the Theory of Gender anPower 
in knowledge and intention to take HPV vaccination and cervical cancer screening in 
Nigeria. Nurses who can access different tribes and region in Nigeria could incorporate 
these theories into intervention strategies aimed at increasing the uptake of HPV vaccine 
and cervical screening.  
Recommendations  
Based on the findings of this research, an effective community-based education 
program for Nigerian urban-dwelling adults should incorporate information that reflects 
the target population’s needs, interests, culture, values and belief. It should also integrate 
activities and recommendations related to primary, secondary, and tertiary levels of 
prevention. This targeted, culturally-tailored community-based educational intervention 
improved awareness, knowledge, and intent to take and or encourage HPV vaccination and 
cervical cancer screening services. The findings indicate that both enhancing public 
understanding of HPV and the relationship of the virus and cervical cancer and increasing 
uptake of effective preventive measures are important steps.  
There are several opportunities for future research pertaining to methodology, 
content area, and refinement of the conceptual framework. More evidence is required to 
further explore the effectiveness of educational interventions in improving HPV and 
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cervical cancer-related stigma in different circumstances, contexts and settings in SSA. 
Similar research should be conducted with larger and more diverse populations in both 
urban and rural areas of Nigeria and further investigators are warranted to assess if 
increased knowledge and intention actually translates into increased uptake of HPV 
vaccination and other preventive measures.  
Due to the geographically limited sample, more widespread implementation among 
different geographic regions ethnic and religious populations across Nigeria is warranted 
in order to would shed light on the long-lasting impact of HPV and cervical cancer 
education. Examples of areas for further investigation include the comparison of HPV 
knowledge, attitudes, and intent among more diverse samples of Nigerian men and women. 
Further research clearly is warranted in the area of stigma and other emotional factors that 
may influence decisions not to participate in HPV vaccination and screening. The roles and 
influence of men, particularly male community leaders, also need to be investigated in 
order to assess their roles in mitigating psychosocial barriers to HPV vaccination and 
screening in diverse areas of SSA.  
Further research is necessary to identify other tailored educational interventions to 
encourage male participation and inclusion in HPV and cervical cancer prevention has 
shown that information without removing the some of the social barriers may not yield the 
desired effects.  There is a need to review and assess the various interventions used to 
increased HPV and cervical cancer knowledge and uptake in Nigeria in order to determine 
their reach and effectiveness. Lastly, it is important to develop culturally appropriate 
evaluation and feedback tools to assess the effectiveness of the programs and help create 
an intervention that is more effective in promoting HPV vaccination and cervical cancer 
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screenings. An understanding of the applicability of the Theory of Gender and Power to 
HPV vaccination and cervical cancer screening among in different cultural backgrounds is 
needed before planning Theory of Gender and Power interventions.  
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APPENDIX A 
INFORMED CONSENT FORM 
Introduction and Purpose  
I am Chigozie Nkwonta, a third year PhD student in the College of Nursing at the 
University of South Carolina, USA. You are invited to take part in my study, which is my 
dissertation. Before you decide whether or not to take part, it is important for you to 
understand why the research is being done and what it will involve. Please take time to 
read the following information carefully.  
 
I am conducting an educational intervention to increase HPV and cervical cancer 
knowledge and intention to screen for and take HPV vaccine. I want to assess what is 
known about HPV and cervical cancer, and if provision of information will increase its 
knowledge and intention to take HPV vaccine and cervical cancer screening. You have 
been purposively chosen to participate in the study because you live in Anambra state and 
is within the age or may have a dependent that is within the age for HPV vaccine and 
cervical cancer screening. If you do decide to take part, the rest of this paper contains 
information on what to expect. Please read it carefully. I am happy to answer any question 
you have about this study before you decide to participate.  
Description of Study Procedures  
If you choose to participate, the researcher will explain the purpose of the study and a step-
by-step procedure for this study. Please, at the end of the information section with the 
researcher, feel very free to ask any questions you may have. Then, you will be asked to 
give consent. You can give verbal or written consent, depending on what you feel most 
comfortable to do. 
 
If you are deemed eligible, you will be enrolled in the study. Once enrolled, you will 
complete a questionnaire at the beginning of the study. The questions contain information 
that describes you, on HPV, cervical cancer, HPV vaccine and cervical cancer screening. 
After completing the questionnaire, the researcher will give a talk on the topics or provide 
you with pamphlets contain information on the topics. After listening to the health talk or 
reading the pamphlets, you will be given the same questionnaire you filled in the beginning 
of the study. If you choose to participate, you do not need to write your name or give any 
information that will identify who you are. The questionnaire will be secured in a locked 
bag and later entered into a password protected computer. The information you filled on 
the questionnaire will be used for my research project. Any identifying information will be 
removed. The study is expected to last no longer than 2 hours, 30 minutes.  
Risk and Benefits of Participation  
There are no known risks associated with this study. However, the questions may cause 
you some discomfort since it involves questions about your personal practice of the HPV 
and cervical cancer preventive measures. Your participation in this study will increases 
your knowledge of HPV, cervical cancer, HPV vaccine and cervical cancer screening. 
Also, your participation will help inform more effective approaches to increasing 
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knowledge HPV and cervical cancer and uptake of the preventive measures. If you wish to 
learn more about the topic confidentially, you can ask further question after the study. I am 
willing and ready to answer your questions or enlighten you more on the topic.  
Confidentiality  
All the information that is collected will be kept strictly confidential. For the purpose of 
this study, your personal identification data such as name or ID number is not needed. 
However, if any detail that can identify you is written on the questionnaire, it will be 
removed when entering the data. An identification number will be assigned to each survey 
to protect your identity. All the information collected will be secured and will be destroyed 
at the end of my doctoral program.  
Voluntary Participation  
Your participation in this study is voluntary. If you decide to take part you are still free to 
withdraw at any time and without giving a reason. You are also free to refuse to answer 
any question. There is no penalty for refusing to participate or dropping from the study.  
Contacts  
Please let me know if you have any questions before you agree to participate. Please let me 
know if you do not understand any question or need more clarification. You may contact 
me at (404) 955-6515 or by email cnkwonta@email.sc.edu if you have any study related 
questions or problems.  
Also, if you have questions or complaints about your treatment as a participant in this study. 
If this happens, you may contact the Office of Research Compliance at the University of 
South Carolina, Columbia, USA at (803) 777-7095. 
Chigozie A. Nkwonta, PhD Candidate, RN/M 
College of Nursing 
University of South Carolina  
Columbia, S.C. 29208 
Deanne Hilfinger-Messias, PhD, RN 
College of Nursing 
University of South Carolina 
Columbia, S.C 29208 
(803) 576-6021 
Signatures/Dates  
Your signature indicates you understood the following information:  
I have read and understood the project information sheet dated 11/20/2017.  
I have been given the opportunity to ask questions about the study.  
I agree to take part in the study.  
I understand that my taking part is voluntary.  
I can withdraw from the study at any time and I will not be asked any questions about 
why I no longer want to take part.  
I understand my personal details such as name, phone number and address will not be 
requested for this study. I will receive a copy of this form.  
I will sign this form as a proof of my consent to participate.  
Signatures/Dates  
_____________________________________  
Participants’ Name  
_____________________________________  
Participants’ Signature/Dates 
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APPENDIX B 
QUESTIONNAIRE FOR MEN 
Section A -Demographic variables 
To begin, I am going to ask you a few questions about yourself 
1) Age (years)________________________________ 
2) Marital status- Single_______ Married________ Others________ 
3) Highest level of education - No formal education_______ Primary education______                    
Secondary education_______ Tertiary education________  
4) Average monthly income (#)- below 50,000____51,000-100,000___above 100,000___ 
Section B -Human Papilloma Virus (HPV) 
5) Have you ever heard of the Human papilloma virus (HPV)? No__ Yes__ Not sure___ 
IF “yes” or “not sure” continue; if your answer is “no”, please go directly to question 
12 
6) How do you think one can get HPV (you can choose more than one answer)?  
______Physical contact  
______Dirty toilets 
______Poor personal hygiene 
______Sexual intercourse 
______I don’t know 
7) How do you know if someone has HPV (you can choose more than one answer)?  
______Itching in the genital area 
______Pain during urination 
______Genital discharges 
______Genital rash 
______No symptoms 
______I don’t know  
8) Who can contract HPV?  
______Male only 
______Female only 
______Male and female 
______I don’t know 
9) Which of the following increases the risk of getting HPV (you can choose more than 
one answer)?  
______Poor diet 
______Smoking 
______Poor personal hygiene 
______Multiple sexual partners  
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______I don’t know 
10) Tick the disease you think HPV can cause?  
______ Cancer of Anus 
______ Cancer of cervix 
______ Genital warts 
______ Cancer of Penis 
______ Cancer of mouth and throat 
______ Cancer of Vagina 
______ I don’t know                                                                                                        
11) How likely do you think you or any of your family member will contract HPV?     
Not Likely__________ Likely_____________ Very likely____________ 
12) Have you heard about HPV vaccine? No______ Yes_____ Not sure_______ 
13) Who can take the vaccine?  
______Boys only 
______ Girls only 
______ Boys and girls  
______ Adult men and women  
______ Children 
______I don’t know         
14) Have you or anyone in your family had HPV vaccine, If Yes, who?      
Me______ Wife_____ Daughter ______Son______ Others______ None______ 
15) How important is it for you or your family member to take HPV vaccine?                                                               
Very important __________Maybe important_________ Not important ___________     
16) Do you plan to take HPV vaccine?   No_________ Yes_________ Maybe_________    
17) Will you encourage your family member or friends to take HPV vaccine?         
No___________ Yes____________ Maybe______________    
18) If yes, why will you get or encourage your family member to take up HPV vaccine? 
______________________________________________________________________ 
19) If no, why will you not get or encourage your family member to take up HPV 
vaccine?_________________________________________________________________ 
20) Who will you encourage to take HPV vaccine (you can choose more than one answer)?     
Wife____ Daughter _____Son_____ Others_____ None_____ 
21) Will you pay to receive or for a family member to get HPV vaccine, If the vaccine cost 
too much?  No___________ Yes____________ Maybe______________    
 
SECTION C: Cervical Cancer 
Now I am going to ask you some questions about cervical cancer. 
22) Have you ever heard of cervical cancer? No______ Yes______ Not sure__________    
23) Which of the following do you think increases the risk of getting cervical cancer (you 
can choose more than one answer)?  
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______ Lack of personal hygiene 
______ Poor diet 
______ Hereditary (run in the family) 
______ Smoking 
______ Multiple sexual partners  
______ I don’t know 
24) Do you think cervical cancer is associated with an infection?  No______ Yes_______ 
25) If yes in question No 20; what type of infection is cervical cancer associated with?  
_______Human immunodeficiency virus (HIV) infection  
_______Syphilis infection 
_______Human papilloma virus (HPV) infection  
_______I don’t know 
26) Cervical cancer is a severe disease.  No_______ Yes_______ 
27) Cervical cancer be prevented?           No_______ Yes_______              
28) Early detection of cervical cancer is helpful?  No_______ Yes_______ 
29) How likely do you think any of your family member will develop cervical cancer  
Not Likely_________ Likely_________ Very likely____________ 
30) Have you heard about Pap smear test or Visual Inspection with Acetic Acid (VIA)?       
No________ Yes_________ Not sure___________ 
31) Have you heard about HPV test?       No________ Yes________ Not sure________ 
32) Who can take Pap smear test or VIA or HPV test?  
_______Men 
_______Women 
_______Boys 
_______Girls  
_______I don’t know  
33) Has anyone in your family had a pap smear, If Yes, who? (you can choose more than 
one answer)?          Wife_______ Daughter_______ Others_______ None_______ 
34) How important is it for your family member to take a Pap smear test?                                                         
Not important_________ Maybe important_________ Very important____________ 
35) Will you encourage any of your family member to receive pap smear?   No________ 
Yes_________ Not sure_________    
36) If yes, why will you encourage your family member to receive pap smear? 
_____________________________________________________________________ 
37) If no, why will you encourage your family member to receive pap smear? 
_____________________________________________________________________ 
38) Will you pay for a family member to receive a pap smear; if the test cost too much?                    
No__________ Yes__________ Not sure_____________    
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Now I am going to ask you some questions about how you see people who had HPV 
infection and cervical cancer 
39) Do you think people with HPV infection sleep with a lot of different people?  
No_______ Yes_________ Not sure__________  
40) Do you think people with cervical cancer sleep with a lot of different people?  
No__________ Yes__________ Not sure__________  
41) Do you think people who have (had) cervical cancer caused their problem? 
No_______ Yes__________ Not sure___________  
42) Do you think that a person affected by cervical cancer is disgusting?  
No__________ Yes__________ Not sure___________  
43) Do you feel uncomfortable around someone affected by cervical cancer? 
No__________ Yes_________ Not sure___________  
44) Do you believe telling someone you have (had) cervical cancer is risky? 
No_________ Yes__________ Not sure___________  
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APPENDIX C 
QUESTIONNAIRE FOR WOMEN 
Section A -Demographic variables 
To begin, I am going to ask you a few questions about yourself 
1) Age (years)________________________________ 
2) Marital status- Single_______ Married________ Others________ 
3) Highest level of education - No formal education________ Primary education______                    
Secondary education________ Tertiary education________ 
4) Average monthly income (#)- below 50,000____51,000-100,000___above 100,000___ 
Section B -Human Papilloma Virus (HPV) 
5) Have you ever heard of the Human papilloma virus (HPV)? No___ Yes___ Not sure___ 
IF “yes” or “not sure” continue; if your answer is “no”, please go directly to question 
12 
6) How do you think one can get HPV (you can choose more than one answer)?  
______Physical contact  
______Dirty toilets 
______Poor personal hygiene 
______Sexual intercourse 
______I don’t know 
7) How do you know if someone has HPV (you can choose more than one answer)?  
______Itching in the genital area 
______Pain during urination 
______Genital discharges 
______Genital rash 
______No symptoms 
______I don’t know  
8) Who can contract HPV?  
______Male only 
______Female only 
______Male and female 
______I don’t know 
9) Which of the following increases the risk of getting HPV (you can choose more than 
one answer)?  
______Poor diet 
______Smoking 
______Poor personal hygiene 
______Multiple sexual partners  
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______I don’t know 
10) Tick the disease you think HPV can cause?  
______ Cancer of Anus 
______ Cancer of cervix 
______ Genital warts 
______ Cancer of Penis 
______ Cancer of mouth and throat 
______ Cancer of Vagina 
______ I don’t know                                                                                                        
11) How likely do you think you or any of your family member will contract HPV?     
Not Likely___________ Likely_____________ Very likely____________ 
12) Have you heard about HPV vaccine? No_______ Yes______ Not sure_______ 
13) Who can take the vaccine?  
______Boys only 
______ Girls only 
______ Boys and girls  
______ Adult men and women  
______ Children 
______I don’t know         
14) Have you or anyone in your family had HPV vaccine, If Yes, who?      
Me______ Husband_____ Son ______ Daughter ______Others _______None______ 
15) How important is it for you or your family member to take HPV vaccine?                                                               
Very important __________Maybe important_________ Not important ___________     
16) Do you plan to take HPV vaccine?   No_________ Yes_________ Maybe_________    
17) Will you encourage your family member to take HPV vaccine?           
No___________ Yes____________ Maybe______________    
18) If yes, why will you get or encourage your family member to take up HPV vaccine? 
______________________________________________________________________ 
19) If no, why will you not get or encourage your family member to take up HPV 
vaccine?_________________________________________________________________ 
20) Who will you encourage to take HPV vaccine (you can choose more than one answer)?     
Daughter _____Son_____ Others_____ None_____ 
21) Will you pay to receive or for a family member to get HPV vaccine, If the vaccine cost 
too much?  No____________ Yes_____________ Maybe______________    
SECTION C: Cervical Cancer 
Now I am going to ask you some questions about cervical cancer. 
22) Have you ever heard of cervical cancer? No______ Yes______ Not sure_________    
23) Which of the following do you think increases the risk of getting cervical cancer (you 
can choose more than one answer)?  
______ Lack of personal hygiene 
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______ Poor diet 
______ Hereditary (run in the family) 
______ Smoking 
______ Multiple sexual partners  
______ I don’t know 
24) Do you think cervical cancer is associated with an infection?  No______ Yes_______ 
25) If yes in question No 20; what type of infection is cervical cancer associated with?  
_______Human immunodeficiency virus (HIV) infection  
_______Syphilis infection 
_______Human papilloma virus (HPV) infection  
_______I don’t know 
26) Cervical cancer is a severe disease.  No______ Yes_______ 
27) Cervical cancer be prevented?           No_______ Yes_______              
28) Early detection of cervical cancer is helpful?  No______ Yes_______ 
29) How likely do you think you or any of your family member will develop cervical cancer  
Not Likely________ Likely________ Very likely____________ 
30) Have you heard about Pap smear test or Visual Inspection with Acetic Acid (VIA)?       
No________ Yes_________ Not sure___________ 
31) Have you heard about HPV test?       No________ Yes________ Not sure________ 
32) Who can take Pap smear test or VIA or HPV test?  
_______Men 
_______Women 
_______Boys 
_______Girls  
_______I don’t know  
33) Have you or anyone in your family had a pap smear, If Yes, who? (you can choose 
more than one answer)? Me______ Daughter_______ Others_____ None_______ 
34) How important is it for you or your family member to take a Pap smear test?                                                         
Not important________ Maybe important________ Very important____________ 
35) Do you plan to go for cervical cancer screening?   No_____ Yes____ Not sure_____    
36) Will you encourage your family member to go for cervical cancer screening?         
No___________ Yes____________ Maybe ______________    
37) If yes, why will you encourage your family member to go for cervical cancer screening? 
___________________________________________________________ 
38) If no, why will you encourage your family member to go for cervical cancer 
screening? ______________________________________________________________
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39) Will you pay to receive or for a family member to receive a pap smear; if the test cost 
too much?  No__________ Yes__________ Not sure____________    
40) I can only take HPV vaccine or screening with my husband’s support? No____Yes___  
41) I need my husband’s permission to use health care services? No____Yes___  
Now I am going to ask you some questions about how you see people who had HPV 
infection and cervical cancer 
42) Do you think people with HPV infection sleep with a lot of different people?  
No_______ Yes_________ Not sure__________  
43) Do you think people with cervical cancer sleep with a lot of different people?  
No__________ Yes__________ Not sure__________  
44) Do you think people who have (had) cervical cancer caused their problem? 
No_______ Yes___________ Not sure___________  
45) Do you think that a person affected by cervical cancer is disgusting?  
No__________ Yes__________ Not sure___________  
46) Do you feel uncomfortable around someone affected by cervical cancer? 
No__________ Yes_________ Not sure___________  
47) Do you believe telling someone you have (had) cervical cancer is risky? 
No__________ Yes_________ Not sure________ 
